Chromosome_position	Variant	Consequence	Exon	Remark
152990663	c.-59C>T   	-	5′ UTR	Benign, based on its frequency of 11/150 inviduals (48) and 1978/21253 (X:152990663 C/T) individuals.
152990698	c.-24_57delinsA	p.0?(no translation initiation)	5′ UTR	Pathogenic, identified in ALD patient (33).
152990700	c.-22C>T 	p.0?upstream ATG (out of frame)	5′ UTR	Pathogenic, identified in ALD patient (32). Affects ALDP stability in patient cells (32).
152990702	c.-20C>T   	-	5′ UTR	Benign, based on its frequency of 54/7395 South Asian individuals (X:152990702 C/T).
152990705	c.-17_8del 	p.0?(no translation initiation)	5′ UTR	Pathogenic, identified in 21 ALD patients (extensive pedigree analysis (45)). No detectable ALDP in patient cells (45).
152990712	c.-10C>T 	p.?	5′ UTR	Status unknown (VUS), identified in ALD newborn screening (191).
152990718	c.-4_5delins10 	p.? 5′ UTR /	exon 1	Pathogenic, identified in ALD newborn screening (191). Deleterious mutation.
152990722	c.1A>G 	p.Met1Val(no translation initiation)	exon 1	Pathogenic, identified in 21 ALD patients (32, 102, 139, 141). No detectable ALDP in patient cells (102, 139, 141).
152990722	c.1A>T 	p.Met1Val(no translation initiation)	exon 1	Pathogenic, identified in ALD patient (160).
152990723	c.2T>A 	p.Met1Lys(no translation initiation)	exon 1	Pathogenic, identified in 5 ALD patients (58). No detectable ALDP in patient cells (58).
152990724	c.3G>A 	p.Met1Ile(no translation initiation)	exon 1	Pathogenic, identified in ALD patient (33).
152990724	c.3G>C 	p.Met1Ile(no translation initiation)	exon 1	Pathogenic, identified in ALD patient (73).
152990740	c.19C>T	p.Pro7Ser	exon 1	VUS (X:152990740 C/T) frequency 1/21371 inviduals.
152990751	c.30G>A	p.Trp10* 	exon 1	Pathogenic, identified in 3 ALD patients (7, 58). No detectable ALDP in patient cells (7).
152990751	c.30G>C	p.Trp10Cys 	exon 1	VUS (X:152990751 G/C) frequency 1/81065 inviduals.
152990753	c.32G>C	p.Arg11Pro 	exon 1	VUS (X:152990753 G/C) frequency 1/21315 inviduals.
152990757	c.36dupG 	p.Asn13Glufs*182 	exon 1	Pathogenic, identified in ALD patient (32). Deleterious mutation.
152990759	c.38A>C	p.Asn13Thr 	exon 1	Benign variant based on 279/103021 inviduals (X:152990759 A/C), confirmed by biochemical testing (48).
152990761	c.40A>G	p.Thr14Ala 	exon 1	VUS (X:152990761 A/G) frequency 6/82276 inviduals.
152990762	c.41C>G	p.Thr14Arg 	exon 1	Benign variant based on 39/103760 inviduals (X:152990762 C/G).
152990767	c.[46A>T; 706C>T]	p.[Lys16*; Arg236Cys]	exon 1	Pathogenic, identified in 2 ALD patients (33). p.Lys16* is a deleterious mutation. Clinical significance of p.Arg236Cys is unclear.
152990771	c.50G>A	p.Arg17His 	exon 1	Benign variant, confirmed by biochemical testing (139).
152990772	c.51_54dup 	p.Ala19Hisfs*177 	exon 1	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
152990776	c.55G>T	p.Ala19Ser 	exon 1	Benign variant, confirmed by biochemical testing (104).
152990778	c.57del	p.Val20Cysfs*48	exon 1	Pathogenic, identified in ALD patient (16). No detectable ALDP in patient cells (146).
152990788	c.67_83del 	p.Ala23Serfs*166 	exon 1	Pathogenic, identified in 2 ALD patients (71, 150). Deleterious mutation.
152990801	c.80A>C	p.Tyr27Ser 	exon 1	Probably pathogenic, identified in ALD patient (181). Additional testing pending.
152990809	c.88dup	p.His30Profs*165 	exon 1	Pathogenic, identified in 2 ALD patients (189). Deleterious mutation.
152990811	c.90C>T	p.His30His 	exon 1	Synonymous (X:152990811 C/T) frequency 5/108570 individuals..
152990813	c.92A>G	p.Lys31Arg 	exon 1	VUS (X:152990813 A/G) frequency 9/88297 individuals.
152990816	c.95T>C	p.Val32Ala 	exon 1	VUS (X:152990816 T/C) frequency 1/88007 inviduals.
152990818	c.97_100del	p.Tyr33Profs*34	exon 1	Pathogenic, identified in ALD patient (48). Deleterious mutation.
152990820	c.99C>A	p.Tyr33* 	exon 1	Pathogenic, identified in ALD patient (105). Deleterious mutation.
152990820	c.99_102del	p.Pro34Trpfs*33	exon 1	Pathogenic, identified in ALD patient (100). Deleterious mutation.
152990821	c.100C>T 	p.Pro34Ser 	exon 1	VUS (X:152990821 C/T).
152990823	c.102delinsAT	p.Leu35Phefs*160 	exon 1	Pathogenic, identified in ALD patient (24). Deleterious mutation.
152990823	c.102dup 	p.Val36Glyfs*159 	exon 1	Pathogenic, identified in ALD patient (120). Deleterious mutation.
152990829	c.108G>A 	p.Val36Val 	exon 1	Synonymous (X:152990829 G/A).
152990830	c.109C>G 	p.Arg37Gly 	exon 1	Pathogenic, identified in ALD patient (32).
152990831	c.110_17del	p.Arg37Profs*155 	exon 1	Pathogenic, identified in 2 ALD patients (33, 72). Deleterious mutation.
152990833	c.112C>T 	p.Gln38* 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990836	c.115_31delinsGCA	p.Cys39Lysfs*151 	exon 1	Pathogenic, identified in ALD patient (60). No detectable ALDP in patient cells (60).
152990840	c.119_47del	p.Leu40Argfs*145 	exon 1	Pathogenic, identified in ALD patient (52). Deleterious mutation.
152990846	c.125delC	p.Pro42Argfs*26	exon 1	Pathogenic, identified in ALD patient (96). Deleterious mutation.
152990846	c.125_26insC 	p.Ala43Glyfs*152 	exon 1	Pathogenic, identified in 3 ALD patients (33, 49). Deleterious mutation.
152990859	c.138_39insT 	p.Gln47Serfs*148 	exon 1	Pathogenic, identified in ALD patient (7). Deleterious mutation.
152990860	c.139C>T 	p.Gln47* 	exon 1	Pathogenic, identified in 4 ALD patients (33, 58, 105). Deleterious mutation. No detectable ALDP in patient cells (58).
152990860	c.139del 	p.Gln47Argfs*21	exon 1	Pathogenic, identified in ALD newborn screening (191). Deleterious mutation.
152990864	c.143C>T 	p.Ala48Val 	exon 1	VUS (X:152990864 C/T) frequency 2/21376 individuals.
152990866	c.145_46insCGAC	p.Ala50Thrfs*146 	exon 1	Pathogenic, identified in ALD patient (63). No detectable ALDP in patient cells (63).
152990868	c.147C>T 	p.Pro49Pro 	exon 1	Synonymous (X:152990868 C/T).
152990871	c.150dup 	p.Gly51Argfs*144 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
152990875	c.154G>T 	p.Glu52* 	exon 1	Pathogenic, identified in ALD patient (38). Deleterious mutation.
152990875	c.154dup 	p.Glu52Glyfs*143 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990876	c.155_56insG 	p.Pro53Alafs*142 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990884	c.163C>T 	p.Gln55* 	exon 1	Pathogenic, identified in ALD patient (100). Deleterious mutation.
152990892	c.171C>G 	p.Ala57Ala 	exon 1	Synonymous (X:152990892 C/G).
152990894	c.173C>G 	p.Ser58Cys 	exon 1	VUS (X:152990894 C/G) frequency 3/103209 individuals.
152990894	c.173C>T 	p.Ser58Phe 	exon 1	VUS (X:152990894 C/T) frequency 9/103209 individuals.
152990902	c.181G>A 	p.Ala61Thr 	exon 1	VUS (X:152990902 G/A) frequency 18/127289 individuals..
152990907	c.186G>A 	p.Ala62Ala 	exon 1	Synonymous (X:152990907 G/A).
152990927	c.206G>A 	p.Arg69Gln 	exon 1	VUS (X:152990927 G/A) frequency 1/21537 individuals.
152990929	c.208G>A 	p.Val70Ile 	exon 1	VUS (X:152990929 G/A) frequency 2/120391 individuals.
152990941	c.220C>T 	p.Arg74Trp 	exon 1	Pathogenic, identified in 9 ALD patients (32, 88, 97, 141). Reduced (7% of control cells) ALDP in patient cells (97).
152990944	c.223_40dup	p.Trp77_Leu82dup 	exon 1	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
152990946	c.225C>T 	p.Leu75Leu 	exon 1	Synonymous (X:152990946 C/T).
152990946	c.225_42del	p.Trp77_Leu82del 	exon 1	Pathogenic, identified in 3 ALD patients (58, 111, 191). No detectable ALDP in patient cells (58).
152990952	c.231G>T 	p.Trp77Cys 	exon 1	VUS (X:152990952 G/T).
152990952	c.231G>A 	p.Trp77* 	exon 1	Pathogenic, idenitified in 4 ALD patients (201). Deleterious mutation.
152990953	c.232_40del	p.Arg80_Leu82del 	exon 1	Pathogenic, identified in 2 ALD patients (38, 58). No detectable ALDP in patient cells (58).
152990955	c.234_42del	p.Arg80_Leu82del 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990955	c.234_42dupCCTGCGGCT 	p.Arg80_Leu82dup 	exon 1	Pathogenic, identified in 5 ALD patients (33, 186). Deleterious mutation.
152990961	c.240_41insTTTGCG	p.Arg80_Leu81insPheAla 	exon 1	Pathogenic, identified in ALD patient (27). Deleterious mutation.
152990961	c.240_41insTCCTGCGGC 	p.Arg80_Leu81insSerCysGly	exon 1	Pathogenic, identified in 2 ALD patients (64, 132). Deleterious mutation.
152990962	c.241C>G 	p.Leu81Val 	exon 1	VUS (X:152990962 C/G) frequency 2/109810 individuals.
152990964	c.244_245insCTGCGGCTC	p.Leu81_Leu82insProAlaAla	exon 1	Pathogenic, identified in 4 ALD patients (28, 33). Deleterious mutation. (Originally reported as: c.243-44insCCTGCGGCT)
152990969	c.248del 	p.Phe83Serfs*20	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990970	c.249C>T 	p.Phe83Phe 	exon 1	Synonymous (X:152990970 C/T) frequency 49/130671 individuals..
152990971	c.250C>T 	p.Pro84Ser 	exon 1	Pathogenic, identified in ALD patient (90).
152990972	c.251C>T 	p.Pro84Leu 	exon 1	Pathogenic, identified in 2 ALD patients (33, 191).
152990974	c.253dup 	p.Arg85Profs*110 	exon 1	Pathogenic, identified in 16 ALD patients (33, 49, 60, 62, 119, 138, 155). No detectable ALDP in patient cells (60).
152990974	c.253del 	p.Arg85Glyfs*18	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152990975	c.254G>T 	p.Arg85Leu 	exon 1	VUS (X:152990975 G/T).
152990977	c.256G>A 	p.Val86Ile 	exon 1	VUS (X:152990977 G/A).
152990977	c.256dup 	p.Val86Glyfs*109 	exon 1	Pathogenic, identified in ALD newborn screening (191). Deleterious mutation.
152990979	c.258C>T 	p.Val86Val 	exon 1	Synonymous (X:152990979 C/T) frequency 113/138493 individuals..
152990979	c.258C>G 	p.Val86Val 	exon 1	Synonymous (X:152990979 C/G).
152990985	c.264C>A 	p.Cys88* 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990985	c.264C>G 	p.Cys88Trp 	exon 1	Pathogenic, identified in 3 ALD patients (63). No detectable ALDP in patient cells (63).
152990986	c.265C>T 	p.Arg89Trp 	exon 1	VUS (X:152990986 C/T).
152990987	c.266G>A 	p.Arg89Gln 	exon 1	VUS (X:152990987 G/A) frequency 2/21458 individuals.
152990989	c.268G>A 	p.Glu90Lys 	exon 1	Pathogenic, identified in 2 ALD patients (49).
152990989	c.268G>T 	p.Glu90* 	exon 1	Pathogenic, identified in ALD patient (141). No detectable ALDP in patient cells (141).
152990991	c.270_71del	p.Glu90Aspfs*104 	exon 1	Pathogenic, identified in 2 ALD patients (93). Deleterious mutation.
152990995	c.274G>A 	p.Gly92Arg 	exon 1	Benign variant based on its frequency of 17/149988 individuals (X:152990995 G/A).
152990995	c.274_311del 	p.Gly92Hisfs*90	exon 1	Pathogenic, identified in 3 ALD patients (4, 158). Deleterious mutation.
152990996	c.275G>T 	p.Gly92Val 	exon 1	VUS (X:152990996 G/T).
152990998	c.277del 	p.Leu93Cysfs*10	exon 1	Pathogenic, identified in ALD patient (16). Deleterious mutation.
152990998	c.277_96dup	p.Ala100Cysfs*10 	exon 1	Pathogenic, identified in 2 ALD patients (111, 149). Deleterious mutation.
152991001	c.280_81insGAGACGGGGCTG	p.Leu94delinsArgAspGlyAlaVal 	exon 1	Pathogenic, identified in ALD patient (96).
152991005	c.284C>A 	p.Ala95Asp 	exon 1	Pathogenic, identified in 6 ALD patients. No detectable ALDP in patient cells (109).
152991008	c.287_88insCC	p.His97Argfs*7 	exon 1	Pathogenic, identified in ALD patient (40). Deleterious mutation.
152991011	c.290A>C 	p.His97Pro 	exon 1	Pathogenic, identified in 4 ALD patients (33, 142, 170).
152991011	c.290A>T 	p.His97Leu 	exon 1	Benign, confirmed by biochemical testing (109).
152991013	c.292T>C 	p.Ser98Pro 	exon 1	Pathogenic, identified in ALD patient (58). Reduced ALDP in patient cells (58).
152991014	c.293C>A 	p.Ser98* 	exon 1	Pathogenic, identified in 2 ALD patients (32, 105). Deleterious mutation.
152991014	c.293C>T 	p.Ser98Leu 	exon 1	Pathogenic, identified in 11 ALD patients (7, 33, 48, 49, 58, 98). Normal ALDP level in patient cells (7), but non-functional.
152991014	c.293C>G 	p.Ser98Trp 	exon 1	Pathogenic, identified in 3 ALD patients (41).
152991015	c.294G>T 	p.Ser98Ser 	exon 1	Synonymous (X:152991015 G/T).
152991015	c.294_95insC 	p.Ala99Argfs*96	exon 1	Pathogenic, identified in ALD patient (38). Deleterious mutation.
152991016	c.295_98dup	p.Ala100Glyfs*96 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991017	c.296C>A 	p.Ala99Asp 	exon 1	Pathogenic, identified in ALD patient (48).
152991019	c.298del 	p.Ala100Profs*3	exon 1	Pathogenic, identified in ALD patient (28). Deleterious mutation.
152991021	c.300C>G 	p.Ala100Ala	exon 1	Synonymous (X:152991021 C/G).
152991022	c.301T>A 	p.Lys101Met	exon 1	Pathogenic, identified in ALD patient (33).
152991026	c.305T>A 	p.Val102Glu	exon 1	Pathogenic, identified in ALD patient (60).
152991030	c.309C>G 	p.Ser103Arg	exon 1	Pathogenic, identified in 2 ALD patients (29, 53). Reduced ALDP in patient cells (53).
152991031	c.310C>T 	p.Arg104Cys	exon 1	Pathogenic, identified in 14 ALD patients (13, 16, 33, 42, 62, 97, 125, 146, 191). Reduced ALDP (35% of control cells) in patient cells (33, 97, 146).
152991032	c.311G>A 	p.Arg104His	exon 1	Pathogenic, identified in 9 ALD patients (4, 32, 33, 47, 49, 132, 137).
152991032	c.311G>T 	p.Arg104Leu	exon 1	Pathogenic, identified in ALD patient (33).
152991032	c.311G>C 	p.Arg104Pro	exon 1	Pathogenic, identified in ALD patient (114).
152991034	c.313A>C 	p.Thr105Pro	exon 1	Pathogenic, identified in 4 ALD patients (33, 38, 158).
152991035	c.314C>T 	p.Thr105Ile	exon 1	Pathogenic, identified in ALD patient (7). No detectable ALDP in patient cells (7).
152991040	c.319del 	p.Leu107Cysfs*91 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991041	c.320T>C 	p.Leu107Pro	exon 1	Pathogenic, identified in 6 ALD patients (15, 178).
152991041	c.320T>G 	p.Leu107Arg	exon 1	Pathogenic, identified in ALD patient (88).
152991042	c.321G>A 	p.Leu107Leu	exon 1	Synonymous (X:152991042 G/A).
152991044	c.323C>A 	p.Ser108*	exon 1	Pathogenic, identified in 4 ALD patients (33, 56, 60, 93). No detectable ALDP in patient cells (60).
152991044	c.[323C>A; 775C>T] 	p.[Ser108*; Arg259Trp] 	exon 1	Pathogenic, identified in ALD patient (86). p.Ser108* is deleterious.
152991044	c.323C>T 	p.Ser108Leu	exon 1	Pathogenic, identified in 13 ALD patients (33, 34, 53, 62, 90, 137, 156, 191). Normal ALDP level in patient cells (53), but non-functional.
152991044	c.323C>G 	p.Ser108Trp	exon 1	Pathogenic, identified in 3 ALD patients (7, 53). Reduced ALDP in patient cells (7).
152991046	c.325del 	p.Val109Cysfs*89 	exon 1	Pathogenic, identified in 3 ALD patients (32). Deleterious mutation.
152991047	c.326T>C 	p.Val109Ala	exon 1	VUS (X:152991047 T/C).
152991058	c.337delC	p.Arg113Alafs*85 	exon 1	Pathogenic, identified in 7 ALD patients (32, 49, 62, 141). No detectable ALDP in patient cells (49, 97, 141).
152991058	c.337C>T 	p.Arg113Cys	exon 1	Pathogenic, identified in 6 ALD patients (32, 49). Normal ALDP level in patient cells (32, 49), but non-functional.
152991059	c.338G>C 	p.Arg113Pro	exon 1	Pathogenic, identified in 4 ALD patients (33, 49).
152991062	c.341T>C 	p.Leu114Pro	exon 1	Pathogenic, identified in 2 ALD patients (33, 53). Reduced ALDP in patient cells (53).
152991067	c.346G>T 	p.Gly116*	exon 1	Pathogenic, identified in 2 ALD patients (137). Deleterious mutation.
152991067	c.346G>A 	p.Gly116Arg	exon 1	Pathogenic, identified in 10 ALD patients (7, 29, 32, 33, 58, 145). Reduced ALDP in patient cells (7).
152991067	c.346G>C 	p.Gly116Arg	exon 1	Pathogenic, identified in ALD patient (33).
152991068	c.347_48delGAinsAT 	p.Gly116Asp	exon 1	Pathogenic, identified in ALD patient (120).
152991068	c.347G>A 	p.Gly116Glu	exon 1	Pathogenic, identified in 3 ALD patients (57, 87, 88)
152991073	c.352delCT 	p.Leu118Glyfs*76 	exon 1	Pathogenic, identified in ALD patient (52). Deleterious mutation.
152991076	c.355del 	p.Ala119Profs*79 	exon 1	Pathogenic, identified in 2 ALD patients (178). Deleterious mutation.
152991076	c.355G>T 	p.Ala119Ser	exon 1	VUS (X:152991076 G/T).
152991077	c.356C>A 	p.Ala119Asp	exon 1	Pathogenic, identified in 2 ALD patients (33).
152991079	c.358C>G 	p.Arg120Gly	exon 1	VUS (X:152991079 C/G) frequency 1/165442 individuals.
152991080	c.359G>A 	p.Arg120His	exon 1	VUS (X:152991080 G/A).
152991080	c.359G>C 	p.Arg120Pro	exon 1	Pathogenic, identified in 5 ALD patients (60). Normal ALDP level in patient cells (60), but non-functional.
152991089	c.368C>T 	p.Ala123Val	exon 1	This was a sequence error in original sequence (18)
152991092	c.371G>C 	p.Arg124Pro	exon 1	Pathogenic, identified in ALD patient (33).
152991092	c.371G>A 	p.Arg124His	exon 1	VUS (X:152991092 G/A) frequency 1/21546 inviduals.
152991096	c.375_78del	p.Lys125Asnfs*72 	exon 1	Pathogenic, identified in ALD patient (123). Deleterious mutation.
152991102	c.381G>A 	p.Pro127Pro	exon 1	Synonymous (X:152991102 G/A).
152991102	c.381G>T 	p.Pro127Pro	exon 1	Synonymous (X:152991102 G/T).
152991103	c.382C>T 	p.Arg128Trp	exon 1	VUS (X:152991103 C/T).
152991104	c.383G>C 	p.Arg128Pro	exon 1	VUS (X:152991104 G/C) frequency 3/171978 inviduals.
152991104	c.383G>A 	p.Arg128Gln	exon 1	VUS (X:152991104 G/A) frequency 3/193580 inviduals.
152991106	c.385dup 	p.Ala129Glyfs*66 	exon 1	Pathogenic, identified in 2 ALD patients (59, 64). Deleterious mutation.
152991108	c.387del 	p.Phe130Leufs*68 	exon 1	Pathogenic, identified in ALD patient (29). Deleterious mutation.
152991110	c.389T>G 	p.Phe130Cys	exon 1	VUS (X:152991110 T/G) frequency 1/21683 inviduals.
152991112	c.391G>C 	p.Gly131Arg	exon 1	VUS (X:152991112 G/C) frequency 1/172406 inviduals.
152991113	c.392G>T 	p.Gly131Val	exon 1	Benign, based on its frequency of 13/171567 inviduals (X:152991113 G/T).
152991116	c.395G>A 	p.Trp132*	exon 1	Pathogenic, identified in 3 ALD patients (71, 94, 150). Deleterious mutation.
152991117	c.396G>A 	p.Trp132*	exon 1	Pathogenic, identified in 8 ALD patients (33, 52, 59, 64, 100, 132, 137). Deleterious mutation.
152991118	c.397C>T 	p.Gln133*	exon 1	Pathogenic, identified in 8 ALD patient (16, 32, 33, 49, 141). No detectable ALDP in patient cells (49, 141).
152991122	c.401T>G 	p.Leu134Arg	exon 1	Pathogenic, identified in ALD patient (95).
152991122	c.401_05delinsAGCATT 	p.Leu134Glnfs*61 	exon 1	Pathogenic, identified in ALD patient (19). Deleterious mutation.
152991127	c.406C>T 	p.Gln136*	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991128	c.407A>G 	p.Gln136Arg	exon 1	VUS (X:152991128 A/G) frequency 1/172655 inviduals
152991131	c.410G>A 	p.Trp137*	exon 1	Pathogenic, identified in 3 ALD patients (96, 98). Deleterious mutation.
152991132	c.411G>A 	p.Trp137*	exon 1	Pathogenic, identified in 6 ALD patients (16, 33, 49, 58, 62). No detectable ALDP in patient cells (49, 146).
152991132	c.411G>T 	p.Trp137Cys	exon 1	Pathogenic, identified in 3 ALD patients (32). No detectable ALDP in patient cells (32).
152991132	c.411_12insC 	p.Leu138Profs*57 	exon 1	Pathogenic, identified in ALD patient (100). Deleterious mutation.
152991133	c.412_23del	p.Leu139_Leu142del 	exon 1	Pathogenic, identified in ALD patient (15). Deleterious mutation.
152991133	c.412_14del	p.Leu139del	exon 1	Pathogenic, identified in 2 ALD patients (52, 96).
152991135	c.414C>T 	p.Leu138Leu	exon 1	Synonymous (X:152991135 C/T).
152991141	c.420C>A 	p.Ile140Ile	exon 1	Synonymous (X:152991141 C/A).
152991141	c.420C>T 	p.Ile140Ile	exon 1	Synonymous (X:152991141 C/T).
152991142	c.421G>A 	p.Ala141Thr	exon 1	Pathogenic, identified in 16 ALD patients (13, 59, 64, 88, 93, 111, 137, 174, 178).
152991143	c.422C>T 	p.Ala141Val	exon 1	Pathogenic, identified in 2 ALD patients (33).
152991145	c.424del 	p.Leu142Serfs*56 	exon 1	Pathogenic, identified in ALD patient (125). Deleterious mutation.
152991145	c.424C>G 	p.Leu142Val	exon 1	VUS (X:152991145 C/G) frequency 3/196447 individuals.
152991147	c.426C>T 	p.Leu142Leu	exon 1	Synonymous (X:152991147 C/T).
152991148	c.427C>G 	p.Pro143Ala	exon 1	Pathogenic, identified in 3 ALD patients (98).
152991148	c.427C>T 	p.Pro143Ser	exon 1	Pathogenic, identified in 5 ALD patients (33, 34, 38, 49, 88).
152991149	c.428C>A 	p.Pro143His	exon 1	Pathogenic, identified in 2 ALD patients (58, 98). Normal ALDP level in patient cells (58), but non-functional.
152991149	c.428C>T 	p.Pro143Leu	exon 1	Pathogenic, identified in ALD patient (33).
152991153	c.432_46delinsCCC	p.Thr145_Ser149delinsPro 	exon 1	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
152991156	c.435C>G 	p.Thr145Thr	exon 1	Synonymous (X:152991156 C/G).
152991157	c.436T>A 	p.Phe146Ile	exon 1	Benign variant based on its frequency 26/197980 inviduals (X:152991157 T/A).
152991157	c.436T>G 	p.Phe146Val	exon 1	VUS (X:152991157 T/G) frequency 1/176235 individuals.
152991160	c.439G>A 	p.Val147Ile	exon 1	VUS (X:152991160 G/A) frequency 2/176480 inviduals.
152991160	c.439_41del	p.Val147del	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991161	c.440T>G 	p.Val147Gly	exon 1	Pathogenic, identified in ALD patients (32). Normal ALDP level in patient cells (32), but non-functional.
152991161	c.442_444delinsTGTTGA	p.Asn148_Thr745delinsCys 	exon 1	Pathogenic, identified in ALD patient (145). Deleterious mutation.
152991163	c.441_442dup 	p.Val147_Asn148insIle	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991163	c.442A>G 	p.Asn148Asp	exon 1	Pathogenic, identified in 2 ALD patients (32, 86).
152991163	c.442A>T 	p.Asn148Tyr	exon 1	Pathogenic, identified in ALD patient (60). Normal ALDP level in patient cells (60), but non-functional.
152991164	c.443A>G 	p.Asn148Ser	exon 1	Pathogenic, identified in 13 ALD patients (7, 8, 24, 33, 38, 60, 93, 98, 158, 192). Normal ALDP level in patient cells (7), but non-functional.
152991164	c.443A>T 	p.Asn148Ile	exon 1	Status unknown (VUS), identified in ALD newborn screening (191).
152991167	c.446G>A 	p.Ser149Asn	exon 1	Pathogenic, identified in 25 ALD patients (16, 32, 49, 97, 141, 146). Reduced ALDP expression (77% of control cells) in patient cells (97).
152991168	c.447T>A 	p.Ser149Arg	exon 1	Pathogenic, identified in ALD patient (188). Mutation affects targeting of ALDP in cells (188).
152991175	c.454C>A 	p.Arg152Ser	exon 1	Pathogenic, identified in 5 ALD patients (29, 33, 49).
152991175	c.454C>T 	p.Arg152Cys	exon 1	Pathogenic, identified in 13 ALD patients (7, 13, 32, 33, 49, 52, 63, 88, 168). Normal ALDP level in patient cells (7, 32, 49, 52), but non-functional.
152991176	c.455G>A 	p.Arg152His	exon 1	VUS (X:152991176 G/A) frequency 1/177452 inviduals
152991176	c.455G>C 	p.Arg152Pro	exon 1	Pathogenic, identified in 2 ALD patients (16, 32). Normal ALDP level in patient cells (32), but non-functional.
152991176	c.455G>T 	p.Arg152Leu	exon 1	Pathogenic, identified in 6 ALD patients (32, 33, 49, 52, 58). Reduced ALDP expression in patient cells (32, 49).
152991182	c.461T>C 	p.Leu154Pro	exon 1	Pathogenic, identified in 3 ALD patients (33, 88).
152991183	c.462_81del	p.Glu155Valfs*33 	exon 1	Pathogenic, identified in ALD patient (44). Deleterious mutation.
152991190	c.469C>T 	p.Gln157*	exon 1	Pathogenic, identified in 4 ALD patients (16, 32, 146). Deleterious mutation. No detectable ALDP in patient cells (146).
152991192	c.471A>G 	p.Gln157Gln	exon 1	Synonymous (X:152991192 A/G).
152991193	c.472C>G 	p.Leu158Val	exon 1	VUS (X:152991193 C/G) frequency 2/177870 individuals.
152991194	c.473T>C 	p.Leu158Pro	exon 1	Pathogenic, identified in 2 ALD patients (33, 125).
152991196	c.475G>A 	p.Ala159Thr	exon 1	VUS (X:152991196 G/A) frequency 2/199788 individuals.
152991197	c.476C>G 	p.Ala159Gly	exon 1	VUS (X:152991197 C/G) frequency 6/177941 individuals.
152991197	c.476_99del	p.Ala159_Leu166del 	exon 1	Pathogenic, identified in 2 ALD patients (33, 96).
152991198	c.477C>T 	p.Ala159Ala	exon 1	Synonymous (X:152991198 C/T).
152991200	c.479T>C 	p.Leu160Pro	exon 1	Pathogenic, identified in 3 ALD patients (70, 111, 158).
152991202	c.481T>C 	p.Ser161Pro	exon 1	Pathogenic, identified in ALD patient (49).
152991203	c.482C>A 	p.Ser161*	exon 1	Pathogenic, identified in 2 ALD patients (29, 88). Deleterious mutation.
152991204	c.483G>A 	p.Ser161Ser	exon 1	Synonymous (X:152991204 G/A).
152991208	c.487C>G 	p.Arg163Gly	exon 1	Pathogenic, identified in ALD patient (163).
152991209	c.488G>A 	p.Arg163His	exon 1	Pathogenic, identified in 2 ALD patients (16, 191). No detectable ALDP in patient cells (32).
152991209	c.488G>T 	p.Arg163Leu	exon 1	Pathogenic, identified in 2 ALD patients (33, 116).
152991209	c.488G>C 	p.Arg163Pro	exon 1	Pathogenic, identified in 9 ALD patients (33, 41, 49, 57).
152991214	c.493C>T 	p.Arg165Cys	exon 1	VUS (X:152991214 C/T) frequency 3/178141 individuals.
152991215	c.494del 	p.Arg165Leufs*33 	exon 1	Pathogenic, identified in ALD patient (52). Deleterious mutation.
152991216	c.495_514del 	p.Leu166Profs*22 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991217	c.496_97insG 	p.Leu166Argfs*29 	exon 1	Pathogenic, identified in 3 ALD patients (61). Deleterious mutation.
152991219	c.498G>T 	p.Leu166Leu	exon 1	Synonymous (X:152991219 G/T).
152991225	c.504C>G 	p.Ala168Ala	exon 1	Synonymous (X:152991225 C/G).
152991227	c.506A>C 	p.His169Pro	exon 1	Pathogenic, identified in ALD patient (145).
152991228	c.507C>T 	p.His169His	exon 1	Synonymous (X:152991228 C/T).
152991229	c.508G>A 	p.Ala170Thr	exon 1	VUS (X:152991229 G/A) frequency 1/178118 inviduals.
152991231	c.510delC	p.Tyr171Thrfs*27 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991232	c.511T>C 	p.Tyr171His	exon 1	VUS (X:152991232 T/C) frequency 1/178233 inviduals.
152991233	c.512A>C 	p.Tyr171Ser	exon 1	Pathogenic, identified in ALD patient (32).
152991235	c.514C>T 	p.Arg172Cys	exon 1	VUS (X:152991235 C/T) frequency 1/178298 inviduals.
152991235	c.514delC	p.Arg172Alafs*26 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991236	c.515G>A 	p.Arg172His	exon 1	VUS (X:152991236 G/A) frequency 5/200163 inviduals.
152991236	c.515_16insC 	p.Leu173Profs*23 	exon 1	Pathogenic, identified in ALD patient (47, 166). Deleterious mutation. No detectable ALDP in patient cells (166).
152991239	c.518T>C 	p.Leu173Pro	exon 1	Pathogenic, identified in ALD patient (52).
152991241	c.520T>C 	p.Tyr174His	exon 1	Pathogenic, identified in ALD patient (33).
152991241	c.520T>G 	p.Tyr174Asp	exon 1	Pathogenic, identified in 3 ALD patients (8, 15).
152991242	c.521A>G 	p.Tyr174Cys	exon 1	Pathogenic, identified in 31 ALD patients (29, 32, 33, 47, 49, 60, 62, 88, 93, 120, 137, 182). No detectable ALDP in patient cells (32, 49, 60).
152991242	c.521A>C 	p.Tyr174Ser	exon 1	Pathogenic, identified in 5 ALD patients (33, 60, 88, 145). Normal ALDP level in patient cells (60), but non-functional.
152991243	c.522_24del	p.Phe175del	exon 1	Pathogenic, identified in ALD patient (53). Reduced ALDP expression in patient cells (53).
152991245	c.524_26del	p.Phe175del	exon 1	Pathogenic, identified in ALD patient (32).
152991247	c.526T>A 	p.Ser176Thr	exon 1	VUS (X:152991247 T/A) frequency 1/178394 inviduals
152991250	c.529C>A 	p.Gln177Lys	exon 1	Pathogenic, identified in ALD patient (93).
152991250	c.529C>T 	p.Gln177*	exon 1	Pathogenic, identified in 14 ALD patients (29, 32, 33, 49, 60, 62, 86, 88, 93, 137, 141). Deleterious mutation. No detectable ALDP expression in patient cells (32, 49, 60, 141).
152991253	c.532C>G 	p.Gln178Glu	exon 1	Pathogenicity of the variant p.Gln178Glu is unclear. It was identified in 3 ALD patients (4, 38), but in combination with a true pathogenic mutation, p.Tyr212*.
152991253	c.[532C>G; 636C>G]  p.[Gln178Glu;	p.Tyr212*] 	exon 1	Pathogenic, identified in 3 ALD patients (4, 38).
152991253	c.532C>T 	p.Gln178*	exon 1	Pathogenic, identified in ALD patient (125). Deleterious mutation.
152991256	c.535A>T 	p.Thr179Ser	exon 1	VUS (X:152991256 A/T) frequency 1/178372 inviduals
152991258	c.537C>T 	p.Thr179Thr	exon 1	Synonymous (X:152991258 C/T).
152991259	c.538T>C 	p.Tyr180His	exon 1	VUS (X:152991259 T/C).
152991261	c.540_41insT 	p.Tyr181Leufs*14 	exon 1	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP expression in patient cells (60).
152991262	c.541_42del	p.Tyr181Profs*13 	exon 1	Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP expression in patient cells (7).
152991263	c.542A>T 	p.Tyr181Phe	exon 1	VUS (X:152991263 A/T) frequency 1/178358 inviduals
152991263	c.542A>G 	p.Tyr181Cys	exon 1	Pathogenic, identified in ALD 6 patients (7, 32, 49, 52, 63, 88). No detectable ALDP in patient cells (32).
152991263	c.542dup 	p.Tyr181*	exon 1	Pathogenic, identified in ALD patient (189). Deleterious mutation.
152991264	c.543C>A 	p.Tyr181*	exon 1	Pathogenic, identified in 7 ALD patients (16, 32, 146). Deleterious mutation. No detectable ALDP in patient cells (32, 146).
152991258	c.544_45insCTACTACC	p.Arg182Profs*19 	exon 1	Pathogenic, identified in ALD patient (49). Deleterious mutation.
152991266	c.545G>C 	p.Arg182Pro	exon 1	Pathogenic, identified in 10 ALD patients (13, 33, 59, 64, 132, 137).
152991269	c.548T>G 	p.Val183Gly	exon 1	Pathogenic, identified in ALD patient (33).
152991276	c.555C>A 	p.Asn185Lys	exon 1	VUS (X:152991276 C/A) frequency 1/178299 inviduals.
152991282	c.561C>T 	p.Asp187Asp	exon 1	Synonymous (X:152991282 C/T).
152991283	c.562G>A 	p.Gly188Arg	exon 1	VUS (X:152991283 G/A) frequency 5/178202 inviduals.
152991284	c.563G>C 	p.Gly188Ala	exon 1	VUS (X:152991284 G/C) frequency 1/178207 inviduals.
152991286	c.565C>T 	p.Arg189Trp	exon 1	Pathogenic, identified in 5 ALD patients (29, 33, 60, 191). Normal ALDP level in patient cells (60), but non-functional.
152991287	c.566G>A 	p.Arg189Gln	exon 1	Pathogenic, identified in ALD patient (33).
152991290	c.569T>C 	p.Leu190Pro	exon 1	Pathogenic, identified in ALD patient (38).
152991293	c.572G>A 	p.Arg191His	exon 1	VUS (X:152991293 G/A) frequency 3/199890 individuals.
152991298	c.577C>T 	p.Pro193Ser	exon 1	VUS (X:152991298 C/T) frequency 1/178086 inviduals.
152991301	c.580G>A 	p.Asp194Asn	exon 1	Pathogenic, identified in 2 ALD patients (16, 58). Affects ALDP stability in patient cells (58).
152991301	c.580G>C 	p.Asp194His	exon 1	Pathogenic, identified in 7 ALD patients (32, 58, 97, 146). Affects ALDP stability (60% of control cells (97)) in patient cells (58, 97, 146).
152991302	c.581_89del	p.Asp194_Leu197delinsVal 	exon 1	Pathogenic, identified in ALD patient (51).
152991303	c.582C>G 	p.Asp194Glu	exon 1	Pathogenic, identified in ALD patient (32).
152991304	c.583C>T 	p.Gln195*	exon 1	Pathogenic, identified in ALD patient (49). Deleterious mutation.
152991309	c.588_89delCT	p.Leu197Aspfs*103	exon 1	Pathogenic, identified in 2 ALD patients (33, 105). Deleterious mutation.
152991312	c.591_92insT 	p.Thr198Tyrfs*103	exon 1	Pathogenic, identified in ALD patient (24). Deleterious mutation.
152991314	c.593C>A 	p.Thr198Lys	exon 1	Pathogenic, identified in ALD patient (49).
152991314	c.593C>G 	p.Thr198Arg	exon 1	Pathogenic, identified in ALD patient (96).
152991314	c.593C>T 	p.Thr198Met	exon 1	Pathogenic, identified in ALD patient (33).
152991315	c.594G>A 	p.Thr198Thr	exon 1	Synonymous (X:152991315 G/A).
152991316	c.595G>A 	p.Glu199Lys	exon 1	Pathogenic, identified in 2 ALD patients (33, 100).
152991319	c.598G>A 	p.Asp200Asn	exon 1	Pathogenic, identified in 2 ALD patients (24, 100).
152991319	c.598delC	p.Asp200Thrfs*16 	exon 1	Pathogenic, identified in ALD patient (90). Deleterious mutation.
152991320	c.599A>T 	p.Asp200Val	exon 1	Pathogenic, identified in ALD patient (7).
152991321	c.600C>T 	p.Asp200Asp	exon 1	Synonymous (X:152991321 C/T).
152991322	c.601G>A 	p.Val201Met	exon 1	Benign variant based on 34/199299 inviduals (X:152991322 G/A).
152991333	c.612del 	p.Phe204Leufs*12 	exon 1	Pathogenic, identified in ALD patient (145). Deleterious mutation.
152991335	c.614C>T 	p.Ala205Val	exon 1	VUS (X:152991335 C/T).
152991335	c.614C>A 	p.Ala205Glu	exon 1	Pathogenic, identified in 2 ALD patients (33).
152991335	c.614_622dup 	p.Ala205_Ser207dup 	exon 1	Pathogenic, identified in 2 ALD patients (29, 49). (Originally reported as c.622_23insCGGCCTCTG).
152991336	c.615G>A 	p.Ala205Ala	exon 1	Synonymous (X:152991336 G/A).
152991339	c.621_900+384del664	p.Val208Trpfs*35 	exon 1	Pathogenic, identified in 5 ALD patient (32, 49, 141). Deleterious mutation. No detectable ALDP expression in patient cells (32, 49, 141).
152991340	c.619_27del	p.Ser207_Ala209del 	exon 1	Pathogenic, identified in ALD patient (62). No detectable ALDP expression in patient cells (62).
152991343	c.622_634del 	p.Val208Thrfs*4	exon 1	Pathogenic, identified in ALD patient (15). Deleterious mutation. (Originally reported as c.618_30del).
152991343	c.622dupG	p.Val208Glyfs*93 	exon 1	Pathogenic, identified in ALD patient (86). Deleterious mutation.
152991344	c.623T>A 	p.Val208Glu	exon 1	Pathogenic, identified in 2 ALD patients (158).
152991349	c.628C>T 	p.His210Tyr	exon 1	Status unknown (VUS), identified in ALD newborn screening (2 cases) (191).
152991353	c.632T>C 	p.Leu211Pro	exon 1	Pathogenic, identified in 2 ALD patients (15, 177).
152991354	c.633C>A 	p.Leu211Leu	exon 1	Synonymous (X:152991354 C/A).
152991357	c.636C>G 	p.Tyr212*	exon 1	Pathogenic, identified in 4 ALD patients (4, 38, 38, 158). Deleterious mutation.
152991359	c.638C>G 	p.Ser213Cys	exon 1	Pathogenic, identified in 2 ALD patients (27, 158).
152991359	c.638C>T 	p.Ser213Phe	exon 1	Pathogenic, identified in ALD patient (32).
152991361	c.640A>G 	p.Asn214Asp	exon 1	Pathogenic, identified in 2 ALD patients (24, 90).
152991364	c.643del 	p.Leu215*	exon 1	Pathogenic, identified in 5 ALD patients (32, 141). Deleterious mutation. No detectable ALDP expression in patient cells (32, 141).
152991370	c.649A>G 	p.Lys217Glu	exon 1	Pathogenic, identified in 6 ALD patients (32, 48, 49, 93, 167). Normal ALDP level in patient cells (49), but non-functional (48).
152991370	c.649A>T 	p.Lys217*	exon 1	Pathogenic, identified in ALD patient (88). Deleterious mutation.
152991373	c.652C>A 	p.Pro218Thr	exon 1	Pathogenic, identified in 6 ALD patients (29, 32, 49, 145). Normal ALDP level in patient cells (32), but non-functional (32).
152991373	c.[652C>T; 664G>T] 	p.[Pro218Ser; Val222Leu] 	exon 1	Pathogenic, identified in 3 ALD patients (98). Unclear which of the variants is pathogenic.
152991374	c.653C>G 	p.Pro218Arg	exon 1	Pathogenic, identified in 3 ALD patients (175).
152991374	c.653C>T 	p.Pro218Leu	exon 1	Pathogenic, identified in ALD patient (33).
152991380	c.659T>C 	p.Leu220Pro	exon 1	Pathogenic, identified in 28 ALD patients (16, 32, 97, 141, 146). Reduced (22% of control cells) ALDP in patient cells (32, 97, 141, 146).
152991381	c.660G>A 	p.Leu220Leu	exon 1	Synonymous (X:152991381 G/A).
152991381	c.660G>T 	p.Leu220Leu	exon 1	Synonymous (X:152991381 G/T).
152991383	c.662_702del 	p.Asp221Valfs*66 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991383	c.662A>G 	p.Asp221Gly	exon 1	Pathogenic, identified in 3 ALD patients (7, 33). No detectable ALDP expression in patient cells (7).
152991385	c.[664G>T;652C>T]	p.[Val222Leu;Pro218Ser]	exon 1	Pathogenic, identified in 3 ALD patients (98). Unclear which of the variants is pathogenic.
152991385	c.664G>A 	p.Val222Met	exon 1	VUS (X:152991385 G/A) frequency 3/176462 inviduals.
152991385	c.664_70dup	p.Val224Glyfs*79 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991388	c.667G>C 	p.Ala223Pro	exon 1	VUS (X:152991388 G/C) frequency 2/198242 inviduals.
152991389	c.668C>T 	p.Ala223Val	exon 1	VUS (X:152991389 C/T) frequency 2/176342 inviduals.
152991389	c.668C>A 	p.Ala223Asp	exon 1	Pathogenic, identified in 2 ALD patients (33, 113).
152991392	c.671T>G 	p.Val224Gly	exon 1	Pathogenic, identified in 2 ALD patients (33, 49).
152991394	c.673A>G 	p.Thr225Ala	exon 1	VUS (X:152991394 A/G) frequency 1/176356 inviduals
152991395	c.674C>T 	p.Thr225Ile	exon 1	VUS (X:152991395 C/T) frequency 1/176348 inviduals.
152991398	c.677del 	p.Tyr227Thrfs*109	exon 1	Pathogenic, identified in 3 ALD patients (29, 33). Deleterious mutation.
152991400	c.679T>C 	p.Tyr227His	exon 1	VUS (X:152991400 T/C) frequency 2/176195 inviduals.
152991402	c.681C>G 	p.Tyr227*	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991402	c.681C>A 	p.Tyr227*	exon 1	Pathogenic, identified in ALD patient (189). Deleterious mutation and biochemically confirmed.
152991404	c.683C>A 	p.Thr228Asn	exon 1	VUS (X:152991404 C/A) frequency 1/176079 inviduals
152991405	c.684_85insTACAC 	p.Leu229Tyrfs*109	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991407	c.686T>C 	p.Leu229Pro	exon 1	Pathogenic, identified in 8 ALD patients (29, 33, 47, 49, 145).
152991412	c.691C>T 	p.Arg231Trp	exon 1	Benign, based on its frequency of 65/197483 inviduals (X:152991412 C/T).
152991413	c.692G>A 	p.Arg231Gln	exon 1	VUS (X:152991413 G/A) frequency 2/175656 inviduals.
152991413	c.692_94delinsC	p.Arg231Profs*69 	exon 1	Pathogenic, identified in ALD patient (172). Deleterious mutation.
152991414	c.693_94del	p.Ala232Glyfs*68 	exon 1	Pathogenic, identified in 2 ALD patients (3, 33). Deleterious mutation. No detectable ALDP expression in patient cells (33).
152991416	c.695_696del 	p.Ala232Glyfs*68 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991416	c.695_96insG 	p.Ala233Glyfs*68 	exon 1	Pathogenic, identified in ALD patient (96). Deleterious mutation.
152991417	c.696_706del11 	p.Ala233Trpfs*64 	exon 1	Pathogenic, identified in ALD patient (100). Deleterious mutation.
152991417	c.696G>T 	p.Ala232Ala	exon 1	Synonymous (X:152991417 G/T) frequency 1/175446 inviduals.
152991417	c.696G>A 	p.Ala232Ala	exon 1	Synonymous (X:152991417 G/A) frequency 1/175276 inviduals.
152991418	c.697_900+25del	p.Ala233Glyfs*100	exon 1	Pathogenic, identified in ALD patient (48). Deleterious mutation.
152991421	c.700C>T 	p.Arg234Cys	exon 1	Status unknown (VUS), identified in ALD newborn screening (191).
152991422	c.701G>A 	p.Arg234His	exon 1	VUS (X:152991422 G/A) frequency 5/197276 inviduals.
152991427	c.706C>T 	p.Arg236Cys	exon 1	Pathogenicity of the variant p.Arg236Cys is unclear (X:152991427 C/T) frequency 2/175366 inviduals). It was also identified in an ALD patient (33), but in combination with a true pathogenic mutation, p.Lys16*
152991427	c.706_09del	p.Arg236Glufs*99 	exon 1	Pathogenic, identified in ALD patient (49). Deleterious mutation.
152991428	c.707G>A 	p.Arg236His	exon 1	Benign, based on its frequency of 253/197189 inviduals (X:152991428 G/A).
152991431	c.710G>T 	p.Gly237Val	exon 1	VUS (X:152991431 G/T).
152991433	c.712G>A 	p.Ala238Thr	exon 1	VUS (X:152991433 G/A).
152991435	c.714C>T 	p.Ala238Ala	exon 1	Synonymous (X:152991435 C/T).
152991436	c.715G>A 	p.Gly239Ser	exon 1	VUS (X:152991436 G/A) frequency 1/175039 inviduals.
152991445	c.724_28del	p.Trp242Leufs*57 	exon 1	Pathogenic, identified in ALD patient (3). Deleterious mutation.
152991446	c.725G>A 	p.Trp242*	exon 1	Pathogenic, identified in ALD patient (96). Deleterious mutation.
152991447	c.726G>A 	p.Trp242*	exon 1	Pathogenic, identified in 6 ALD patients (15, 33, 49, 59, 64, 132). Deleterious mutation. No detectable ALDP in patient cells (49).
152991451	c.730delT	p.Ser244Argfs*92 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991451	c.730_31delinsGAGA 	p.Ser244Glufs*93 	exon 1	Pathogenic, identified in 4 ALD patients (37). Deleterious mutation.
152991452	c.731C>T 	p.Ser244Leu	exon 1	VUS (X:152991452 C/T) frequency 2/173152 inviduals.
152991453	c.732G>A 	p.Ser244Ser	exon 1	Synonymous (X:152991453 G/A).
152991455	c.734C>A 	p.Ala245Asp	exon 1	Pathogenic, identified in ALD patient (32, 141). Normal ALDP level in patient cells (32, 141), but non-functional (32, 141).
152991456	c.735C>T 	p.Ala245Ala	exon 1	Synonymous (X:152991456 C/T).
152991460	c.739G>A 	p.Ala247Thr	exon 1	VUS (X:152991460 G/A).
152991460	c.739delG	p.Ala247Profs*89 	exon 1	Pathogenic, identified in ALD patient (52). Deleterious mutation.
152991460	c.739_40insGCCATCG 	p.Ala247Glyfs*56 	exon 1	Pathogenic, identified in ALD patient (93). Deleterious mutation.
152991463	c.742G>A 	p.Gly248Ser	exon 1	VUS (X:152991463 G/A) frequency 7/194293 inviduals.
152991463	c.742_45del	p.Gly248Serfs*87 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991469	c.748_59del	p.Val250_Leu253del 	exon 1	Pathogenic, identified in ALD patient (33).
152991470	c.749_51del	p.Val251del	exon 1	Pathogenic, identified in ALD patient (33).
152991471	c.750G>A 	p.Val250Val	exon 1	Synonymous (X:152991471 G/A).
152991478	c.757C>G 	p.Leu253Val	exon 1	Benign, based on its frequency of 151/191124 inviduals (X:152991478 C/G).
152991478	c.757_65delinsGAGG 	p.Leu253Glufs*46 	exon 1	Pathogenic, identified in ALD patient (60). Deleterious mutation.
152991482	c.760A>G 	p.Thr254Ala	exon 1	Pathogenic, identified in ALD patient (33, 58). Normal ALDP level in patient cells (58), but non-functional (58).
152991481	c.760A>C 	p.Thr254Pro	exon 1	Pathogenic, identified in 3 ALD patients (33, 90).
152991481	c.761delC	p.Thr254Argfs*82 	exon 1	Pathogenic, identified in 2 ALD patients (81, 104). Deleterious mutation.
152991482	c.761C>A 	p.Thr254Lys	exon 1	Pathogenic, identified in 2 ALD patients (33, 52).
152991482	c.761C>T 	p.Thr254Met	exon 1	Pathogenic, identified in 6 ALD patients (15, 33, 105).
152991484	c.763G>A 	p.Ala255Thr	exon 1	VUS (X:152991484 G/A).
152991489	c.768C>T 	p.Asn256Asn	exon 1	Synonymous (X:152991489 C/T).
152991490	c.769G>A 	p.Val257Met	exon 1	VUS (X:152991490 G/A) frequency 1/163453 inviduals
152991494	c.773T>C 	p.Leu258Pro	exon 1	Pathogenic, identified in ALD patient (33).
152991496	c.775C>T 	p.Arg259Trp	exon 1	Pathogenicity of the variant p.Arg259Trp is unclear (X:152991496 C/T) frequency 2/157411 individuals. It was identified in an ALD patient (167), but in combination with a true pathogenic mutation, p.Ser108*.
152991497	c.776G>A 	p.Arg259Gln	exon 1	VUS (X:152991497 G/A).
152991499	c.778G>A 	p.Ala260Thr	exon 1	VUS (X:152991499 G/A) frequency 1/156948 inviduals
152991505	c.784_785del 	p.Ser262Alafs*38 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991506	c.785_91del	p.Ser262Cysfs*72 	exon 1	Pathogenic, identified in 4 ALD patients (16). Deleterious mutation.
152991506	c.785C>A 	p.Ser262*	exon 1	Pathogenic, identified in ALD patient (120). Deleterious mutation.
152991506	c.785C>G 	p.Ser262Trp	exon 1	Pathogenic, identified in ALD patient (32).
152991508	c.787C>T 	p.Pro263Ser	exon 1	Pathogenic, identified in ALD patient (33).
152991509	c.788C>T 	p.Pro263Leu	exon 1	Pathogenic, identified in ALD patient (7). Affects ALDP stability in patient cells (7).
152991511	c.790A>T 	p.Lys264*	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991511	c.790A>C 	p.Lys264Gln	exon 1	VUS (X:152991511 A/C) frequency 1/21836 inviduals
152991517	c.796G>A 	p.Gly266Arg	exon 1	Pathogenic, identified in 33 ALD patients (8, 16, 24, 33, 49, 52, 53, 59, 62, 64, 67, 72, 88, 90, 93, 96, 105, 132, 137, 162). Normal ALDP level in patient cells (53, 72), but non-functional.
152991517	c.796G>C 	p.Gly266Arg	exon 1	Pathogenic, identified in ALD patient (58). Normal ALDP level in patient cells (58), but non-functional.
152991518	c.797G>A 	p.Gly266Glu	exon 1	Pathogenic, identified in 3 ALD patients (49, 96).
152991520	c.799G>A 	p.Glu267Lys	exon 1	Pathogenic, identified in ALD patient (51).
152991520	c.799G>T 	p.Glu267*	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991520	c.799del 	p.Glu267Serfs*69 	exon 1	Pathogenic, identified in ALD patient (15). Deleterious mutation.
152991530	c.809C>T 	p.Ala270Val	exon 1	VUS (X:152991530 C/T) frequency 5/165970 inviduals.
152991532	c.811G>A 	p.Glu271Lys	exon 1	Pathogenic, identified in ALD patient (24).
152991536	c.815_17del	p.Glu272del	exon 1	Pathogenic, identified in 3 ALD patients (33, 191).
152991539	c.818C>A 	p.Ala273Glu	exon 1	Pathogenic, identified in ALD patient (58). Normal ALDP level in patient cells (58), but non-functional.
152991540	c.819G>A 	p.Ala273Ala	exon 1	Synonymous (X:152991540 G/A).
152991541	c.820C>T 	p.Arg274Trp	exon 1	VUS (X:152991541 C/T). Identified in 2/31066 inviduals.
152991541	c.[820C>T; 838C>T] 	p.[Arg274Trp; Arg280Cys] 	exon 1	Pathogenic, identified in ALD patient (49). p.Arg274Trp is most likely benign and p.Arg280Cys is pathogenic.
152991542	c.821G>A 	p.Arg274Gln	exon 1	VUS (X:152991542 G/A) frequency 1/21809 inviduals.
152991544	c.823C>T 	p.Arg275Trp	exon 1	Pathogenic, identified in 8 ALD patients (extended family screening) (181).
152991547	c.826A>G 	p.Lys276Glu	exon 1	Pathogenic, identified in 2 ALD patients (22, 86). Normal ALDP level in patient cells (22), but non-functional.
152991549	c.828_29insAAT 	p.Gly277_Glu278insAsn	exon 1	Pathogenic, identified in 2 ALD patients (15, 158).
152991550	c.829G>A 	p.Gly277Arg	exon 1	Pathogenic, identified in 5 ALD patients (15, 33, 60, 88). Normal ALDP level in patient cells (60), but non-functional.
152991550	c.829G>C 	p.Gly277Arg	exon 1	Pathogenic, identified in 4 ALD patients (27, 60). Normal ALDP level in patient cells (60), but non-functional.
152991550	c.829G>T 	p.Gly277Trp	exon 1	Pathogenic, identified in 2 ALD patients (13, 27).
152991551	c.830G>A 	p.Gly277Glu	exon 1	Pathogenic, identified in 2 ALD patients (33, 191).
152991553	c.832G>A 	p.Glu278Lys	exon 1	VUS (X:152991553 G/A).
152991553	c.832G>T 	p.Glu278*	exon 1	Pathogenic, identified in 3 ALD patients (32, 58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991553	c.832_34delinsAC 	p.Glu278Thrfs*58 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991557	c.836T>C 	p.Leu279Pro	exon 1	Pathogenic, identified in ALD patient (60). No detectable ALDP expression in patient cells (60).
152991558	c.837G>A 	p.Leu279Leu	exon 1	Synonymous (X:152991558 G/A).
152991559	c.838C>A 	p.Arg280Ser	exon 1	VUS (X:152991559 C/A).
152991559	c.838C>T 	p.Arg280Cys	exon 1	Pathogenic, identified in 11 ALD patients (32, 33, 50, 60, 191, 193). Normal ALDP level in patient cells (60), but non-functional.
152991560	c.839G>A 	p.Arg280His	exon 1	Status unknown (VUS), identified in ALD newborn screening (2 siblings) (191).
152991560	c.839G>T 	p.Arg280Leu	exon 1	Pathogenic, identified in 2 ALD patients (55, 93).
152991568	c.847C>T 	p.His283Tyr	exon 1	Pathogenic, identified in 5 ALD patients (32, 141). Affects ALDP stability in patient cells (32, 141).
152991568	c.847C>G 	p.His283Asp	exon 1	Pathogenic, identified in 5 ALD patients (59, 64, 93, 132, 137).
152991569	c.848A>G 	p.His283Arg	exon 1	Pathogenic, identified in 7 ALD patients (89, 93, 173).
152991572	c.851C>A 	p.Ser284*	exon 1	Pathogenic, identified in ALD patient (32). Deleterious mutation. No detectable ALDP expression in patient cells (32).
152991572	c.851C>G 	p.Ser284Trp	exon 1	Status unknown (VUS), identified in ALD newborn screening (191).
152991573	c.852_53insACTC	p.Arg285Thrfs*17 	exon 1	Pathogenic, identified in 2 ALD patients (33, 104). Deleterious mutation.
152991573	c.852dup 	p.Arg285Alafs*16 	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991574	c.853C>A 	p.Arg285Ser	exon 1	Status unknown (VUS), identified in ALD newborn screening (2 siblings) (191).
152991574	c.853C>G 	p.Arg285Gly	exon 1	Pathogenic, identified in ALD patient (145).
152991575	c.854G>C 	p.Arg285Pro	exon 1	Pathogenic, identified in 2 ALD patients (27, 49).
152991575	c.854G>A 	p.Arg285His	exon 1	VUS (X:152991575 G/A) frequency 1/21761 inviduals
152991580	c.859G>T 	p.Val287Leu	exon 1	VUS (X:152991580 G/T).
152991590	c.869del 	p.Ser290Trpfs*46 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991590	c.869C>G 	p.Ser290Trp	exon 1	Pathogenic, identified in ALD patient (90).
152991590	c.869C>A 	p.Ser290*	exon 1	Pathogenic, identified in ALD patient (49). Deleterious mutation. No detectable ALDP expression in patient cells (49).
152991592	c.871G>A 	p.Glu291Lys	exon 1	Pathogenic, identified in 7 ALD patients (5, 58, 59, 60, 64, 132, 137). No detectable ALDP expression in patient cells (58, 60).
152991593	c.872A>G 	p.Glu291Gly	exon 1	Pathogenic, identified in 3 ALD patients (145).
152991594	c.873G>C 	p.Glu291Asp	exon 1	Pathogenic, identified in 2 ALD patients (22, 33). No detectable ALDP expression in patient cells (22, 33).
152991595	c.874_76delGAG 	p.Glu292del	exon 1	Pathogenic, identified in 22 ALD patients (15, 22, 24, 31, 32, 33, 49, 178). No detectable ALDP expression in patient cells (22, 32, 33, 49). (Also reported as p.Glu291del).
152991595	c.874G>A 	p.Glu292Lys	exon 1	Pathogenic, identified in 2 ALD patients (184).
152991601	c.880G>A 	p.Ala294Thr	exon 1	Pathogenic, identified in 3 ALD patients (7, 32, 191).
152991602	c.881C>T 	p.Arg294Val	exon 1	Pathogenic, identified in ALD patient (33).
152991603	c.882_883insGC 	p.Phe295Alafs*42 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991606	c.885delinsTA	p.Tyr296Ilefs*5	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991607	c.886_99del14	p.Tyr296Glyfs*100	exon 1	Pathogenic, identified in ALD patient (27). Deleterious mutation.
152991607	c.886T>C 	p.Tyr296His	exon 1	Pathogenic, identified in ALD patient (33).
152991608	c.887A>G 	p.Tyr296Cys	exon 1	Pathogenic, identified in 26 ALD patients (24, 33, 49, 52, 59, 62, 64, 88, 100, 115, 125, 132, 137). Normal ALDP level in patient cells (58), but non-functional.
152991608	c.887A>C 	p.Tyr296Ser	exon 1	Pathogenic, identified in ALD patient (33).
152991609	c.888T>G 	p.Tyr296*	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991613	c.892G>C 	p.Gly298Arg	exon 1	Pathogenic, identified in ALD patient (125).
152991613	c.892G>A 	p.Gly298Ser	exon 1	Pathogenic, identified in 5 ALD patients (32, 33).
152991613	c.892_96delinsGTCA 	p.Gly298Valfs*38 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991613	c.892_93insGC	p.His299Profs*38 	exon 1	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991614	c.893G>A 	p.Gly298Asp	exon 1	Pathogenic, identified in ALD patient (29, 38, 58, 125). No detectable ALDP expression in patient cells (58).
152991614	c.893G>T 	p.Gly298Val	exon 1	Pathogenic, identified in ALD patient (33).
152991614	c.893_94delinsT	p.Gly298Valfs*38 	exon 1	Pathogenic, identified in ALD patient (53, 84). Deleterious mutation. No detectable ALDP expression in patient cells (53).
152991614	c.893_894insG	p.His299Alafs*2	exon 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991616	c.895C>T 	p.His299Tyr	exon 1	Benign, based on frequency (23/112915 inviduals (X:152991616 C/T).
152991617	c.896A>G 	p.His299Arg	exon 1	Pathogenic, identified in ALD patient (32).
152991621	c.900G>A 	p.Val301fs*34	exon 1	Pathogenic, identified in 3 ALD patients (33, 53, 152). Reduced (7% of control cells) ALDP in patient cells due to splicing defect (152).
152991622	c.900+1G>T 	p.Val301fs*? 	IVS 1	Pathogenic, identified in 4 ALD patients (49, 59, 64, 132). Deleterious mutation.
152991622	c.900+1G>A 	p.Val301fs*? 	IVS 1	Pathogenic, identified in 3 ALD patients (33, 100, 117). Deleterious mutation.
152991623	c.900+2T>C 	p.Val301fs*? 	IVS 1	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991633	c.900+12T>A  	-	IVS 1	VUS (X:152991633 T/A) frequency 1/76302 individuals.
152991648	c.900+27G>A  	-	IVS 1	VUS (X:152991648 G/A) frequency 9/88236 inviduals.
152991651	c.900+30G>A  	-	IVS 1	VUS (X:152991651 G/A) frequency 10/87692 inviduals.
152994671	c.901-16C>T  	-	IVS 1	Benign, based on its frequency of 1567/199361 inviduals (X:152994671 C/T).
152994677	c.901-10C>T  	-	IVS 1	Benign, based on its frequency of 720/199300 inviduals (X:152994677 C/T).
152994678	c.901-9C>A   	-	IVS 1	VUS (X:152994678 C/A) frequency 1/177868 individuals.
152994682	c.901-5C>T   	-	IVS 1	Benign, based on its frequency of 46/199618 inviduals (X:152994682 C/T).
152994683	c.901-4G>A   	-	IVS 1	VUS (X:152994683 G/A) frequency 3/178069 individuals.
152994684	c.901-3C>G 	p.Val301fs*? 	IVS 1	Pathogenic, identified in ALD patient (60). No detectable ALDP in patient cells (60).
152994685	c.901-2A>C 	p.Val301fs*? 	IVS 1	Pathogenic, identified in ALD patient (68). Deleterious mutation.
152994686	c.901-1G>A 	p.Val301fs*? 	IVS 1	Pathogenic, identified in 6 ALD patients (33, 49, 62, 111, 125). Deleterious mutation.
152994690	c.904G>A 	p.Glu302Lys	exon 2	Pathogenic, identified in 5 ALD patients (21, 58, 72, 191). Affects ALDP stability in patient cells (58, 72).
152994690	c.904G>C 	p.Glu302Gln	exon 2	Pathogenic, identified in ALD patient (32).Affects ALDP stability in patient cells (32).
152994691	c.905A>T 	p.Glu302Val	exon 2	Pathogenic, identified in ALD patient (88).
152994691	c.905A>G 	p.Glu302Gly	exon 2	Pathogenic, identified in ALD patient (33).
152994692	c.906G>A 	p.Glu302Glu	exon 2	Synonymous (X:152994692 G/A).
152994692	c.906G>C 	p.Glu302Asp	exon 2	Pathogenic, identified in ALD patient (137).
152994696	c.910G>A 	p.Ala304Thr	exon 2	VUS (X:152994696 G/A) frequency 2/178390 individuals.
152994696	c.910del 	p.Ala304Profs*32 	exon 2	Pathogenic, identified in ALD patient (84). Deleterious mutation.
152994699	c.913C>T 	p.Leu305Leu	exon 2	VUS (X:152994699 C/T) frequency 2/178390 inviduals
152994705	c.919C>T 	p.Gln307*	exon 2	Pathogenic, identified in 5 ALD patients (62, 63, 127). Deleterious mutation.
152994707	c.921G>A 	p.Gln307Gln	exon 2	Synonymous (X:152994707 G/A).
152994708	c.922C>T 	p.Arg308Cys	exon 2	VUS (X:152994708 C/T) frequency 4/200081 inviduals.
152994709	c.923G>A 	p.Arg308His	exon 2	VUS (X:152994709 G/A) frequency 5/178473 inviduals.
152994717	c.931C>T 	p.Gln311*	exon 2	Pathogenic, identified in 4 ALD patients (2, 60). Deleterious mutation. No detectable ALDP in patient cells (60).
152994718	c.932dup 	p.Asp312Glyfs*89 	exon 2	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152994719	c.933_34insA 	p.Asp312Argfs*89 	exon 2	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
152994721	c.935del 	p.Asp312Alafs*24 	exon 2	Pathogenic, identified in 2 ALD patient (35). Deleterious mutation.
152994722	c.936C>G 	p.Asp312Glu	exon 2	VUS (X:152994722 C/G).
152994723	c.937delC	p.Leu313Trpfs*23 	exon 2	Pathogenic, identified in ALD patient (59, 64). Deleterious mutation.
152994724	c.938T>C 	p.Leu313Pro	exon 2	Pathogenic, identified in 3 ALD patients (33, 88, 90).
152994726	c.940G>C 	p.Ala314Pro	exon 2	Pathogenic, identified in ALD patient (93).
152994729	c.943del 	p.Ser315Argfs*21 	exon 2	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
152994730	c.944C>T 	p.Ser315Leu	exon 2	VUS (X:152994730 C/T) frequency 2/178647 inviduals.
152994730	c.944C>A 	p.Ser315*	exon 2	Pathogenic, identified in ALD patient (49). Deleterious mutation.
152994731	c.945G>A 	p.Ser315Ser	exon 2	Synonymous (X:152994731 G/A).
152994733	c.947A>C 	p.Gln316Pro	exon 2	Pathogenic, identified in 2 ALD patients (129).
152994739	c.953A>G 	p.Asn318Ser	exon 2	VUS (X:152994739 A/G) frequency 1/178710 inviduals
152994750	c.964C>A 	p.Leu322Met	exon 2	VUS (X:152994750 C/A) frequency 1/178734 inviduals.
152994751	c.965T>C 	p.Leu322Pro	exon 2	Pathogenic, identified in 4 ALD patients (26, 33, 62, 135).
152994754	c.968A>T 	p.Glu323Val	exon 2	VUS (X:152994754 A/T) frequency 1/178740 inviduals.
152994756	c.970C>T 	p.Arg324Cys	exon 2	Pathogenic, identified in ALD patient (191, 200).
152994757	c.971G>A 	p.Arg324His	exon 2	VUS (X:152994757 G/A).
152994760	c.974T>C 	p.Leu325Pro	exon 2	Pathogenic, identified in 3 ALD patients (33, 125).
152994763	c.977G>A 	p.Trp326*	exon 2	Pathogenic, identified in 3 ALD patients (2, 60, 154). Deleterious mutation.
152994764	c.978G>A 	p.Trp326*	exon 2	Pathogenic, identified in ALD patient (100). Deleterious mutation.
152994765	c.979_80insT 	p.Tyr327Leufs*74 	exon 2	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP expression in patient cells (60).
152994767	c.981T>A 	p.Tyr327*	exon 2	Pathogenic, identified in ALD patient (38). Deleterious mutation.
152994768	c.982G>T 	p.Val328Phe	exon 2	Pathogenic, identified in ALD patient (120).
152994771	c.985A>C 	p.Met329Leu	exon 2	VUS (X:152994771 A/C) frequency 1/178746 inviduals
152994772	c.986T>C 	p.Met329Thr	exon 2	VUS (X:152994772 T/C) frequency 2/178750 inviduals
152994772	c.986T>G 	p.Met329Arg	exon 2	Pathogenic, identified in ALD patient (33).
152994774	c.988_1005del	p.Leu330_Met335del 	exon 2	Pathogenic, identified in ALD patient (33).
152994777	c.991G>A 	p.Glu331Lys	exon 2	Pathogenic, identified in ALD patient (33).
152994777	c.991G>T 	p.Glu331*	exon 2	Pathogenic, identified in ALD patient (58). Deleterious mutation.
152994780	c.994C>T 	p.Gln332*	exon 2	Pathogenic, identified in 2 ALD patients (63, 165). Deleterious mutation. No detectable ALDP expression in patient cells (63).
152994787	c.1001T>C	p.Leu334Pro	exon 2	Pathogenic, identified in ALD patient (33).
152994790	c.1004T>G	p.Met335Arg	exon 2	Pathogenic, identified in ALD patient (33).
152994793	c.1007A>T	p.Lys336Met	exon 2	Pathogenic, identified in ALD patient (49).
152994794	c.1008G>T	p.Lys336Asn	exon 2	Pathogenic, identified in ALD patient (32).
152994794	c.1008G>C	p.Lys336Asn	exon 2	Pathogenic, identified in ALD patient (145).
152994795	c.1009T>C	p.Tyr337His	exon 2	Pathogenic, identified in ALD patient (33).
152994797	c.1011T>A	p.Tyr337*	exon 2	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152994800	c.1014G>A	p.Val338Val	exon 2	Synonymous (X:152994800 G/A).
152994801	c.1015T>C	p.Trp339Arg	exon 2	Pathogenic, identified in ALD patient (38).
152994801	c.1015T>G	p.Trp339Gly	exon 2	Pathogenic, identified in 2 ALD patients (186).
152994802	c.1016G>C	p.Trp339Ser	exon 2	Pathogenic, identified in ALD patient (145).
152994802	c.1016G>A	p.Trp339*	exon 2	Pathogenic, identified in ALD patient (33). Deleterious mutation.
152994803	c.1017G>A	p.Trp339*	exon 2	Pathogenic, identified in 2 ALD patients (33). Deleterious mutation.
152994803	c.1017G>T	p.Trp339Cys	exon 2	Pathogenic, identified in ALD patient (125).
152994806	c.1020C>T	p.Ser340Ser	exon 2	Synonymous (X:152994806 C/T).
152994807	c.1021G>A	p.Ala341Thr	exon 2	VUS (X:152994807 G/A) frequency 1/178613 inviduals.
152994807	c.1021G>T	p.Ala341Ser	exon 2	VUS (X:152994807 G/T) frequency 9/178613 inviduals.
152994808	c.1022C>A	p.Ala341Asp	exon 2	Pathogenic, identified in ALD patient (104). Confirmed by functional studies (104).
152994810	c.1024T>C	p.Ser342Pro	exon 2	Pathogenic, identified in 3 ALD patients (22, 33). Normal ALDP level in patient cells (22, 33), but non-functional (22, 33).
152994811	c.1025C>T	p.Ser342Leu	exon 2	Status unknown (VUS), identified in ALD newborn screening (191).
152994813	c.1027G>A	p.Gly343Ser	exon 2	Pathogenic, identified in 2 ALD patients (63, 165).
152994814	c.1028G>A	p.Gly343Asp	exon 2	Pathogenic, identified in 2 ALD patients (33, 49).
152994814	c.1028G>T	p.Gly343Val	exon 2	Pathogenic, identified in 12 ALD patients (59, 64, 93, 108, 132, 137, 145, 174).
152994817	c.1031T>C	p.Leu344Pro	exon 2	Pathogenic, identified in ALD patient (33).
152994822	c.1036A>G	p.Met346Val	exon 2	Status unknown (VUS), identified in ALD newborn screening (191).
152994833	c.1047C>A	p.Val349Val	exon 2	Synonymous (X:152994833 C/A).
152994836	c.1050del	p.Ile351Serfs*15 	exon 2	Pathogenic, identified in ALD patient (32). Deleterious mutation.
152994854	c.1068C>T	p.Gly356Gly	exon 2	Synonymous (X:152994854 C/T).
152994855	c.1069_70delTinsGCC	p.Tyr357Alafs*10 	exon 2	Pathogenic, identified in 2 ALD patients (38). Deleterious mutation.
152994858	c.1072T>C	p.Ser358Pro	exon 2	Benign variant (X:152994858 T/C) frequency 3/177946 inviduals, confirmed by biochemical testing (139).
152994859	c.1073C>G	p.Ser358*	exon 2	Pathogenic, identified in 4 ALD patients (60, 100, 154, 191). Deleterious mutation. No detectable ALDP expression in patient cells (60).
152994860	c.1074_75insA	p.Glu359Argfs*42 	exon 2	Pathogenic, identified in ALD patient (100). Deleterious mutation.
152994862	c.1076_77delAG 	p.Glu359Argfs*41 	exon 2	Pathogenic, identified in 2 ALD patients (37, 145). Deleterious mutation.
152994865	c.1079C>G	p.Ser360*	exon 2	Pathogenic, identified in 2 ALD patients (33). Deleterious mutation.
152994868	c.1081+1G>T	p.Asp361fs*? 	IVS 2	Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
152994872	c.1081+5G>T	p.Asp361fs*? 	IVS 2	Pathogenic, identified in 2 ALD patients (32, 104). Deleterious mutation. No detectable ALDP expression in patient cells (104).
152994875	c.1081+8C>T  	-	IVS 2	VUS (X:152994875 C/T) frequency 1/177225 individuals.
153001534	c.1082-32>delC   	-	IVS 2	Benign, based on its frequency of 81/190710 inviduals (X:153001534 GC/G)
153001535	c.1082-31C>T   	-	IVS 2	VUS (X:153001535 C/T) frequency 3/171145 individuals.
153001539	c.1082-27G>A   	-	IVS 2	VUS (X:153001539 G/A) frequency 4/172834 individuals.
153001546	c.1082-20A>G   	-	IVS 2	VUS (X:153001546 A/G)
153001547	c.1082-19C>G   	-	IVS 2	Benign, based on its frequency of 84/197384 inviduals (X:153001547 C/G)
153001551	c.1082-15T>C   	-	IVS 2	VUS (X:153001551 T/C).
153001566	c.1082A>G	p.Asp361Gly	exon 3	VUS (X:153001566 A/G) frequency 3/177457 inviduals.
153001567	c.1083T>A	p.Asp361Glu	exon 3	VUS (X:153001567 T/A) frequency 1/177463 inviduals.
153001567	c.1083T>C	p.Asp361Asp	exon 3	Synonymous (X:153001567 T/C).
153001568	c.1084G>A	p.Ala362Thr	exon 3	VUS (X:153001568 G/A) frequency 1/177465 inviduals
153001574	c.1090del	p.Ala364Profs*2	exon 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001576	c.1092del	p.Ala365*	exon 3	Pathogenic, identified in ALD patient (48). Deleterious mutation.
153001576	c.1092_93insA	p.Val365Serfs*36 	exon 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001576	c.1092C>T	p.Ala364Ala	exon 3	Synonymous (X:153001576 C/T).
153001577	c.1093G>A	p.Val365Met	exon 3	VUS (X:153001577 G/A) frequency 5/177817 controle alleles..
153001577	c.1093G>C	p.Val365Leu	exon 3	VUS (X:153001577 G/C) frequency 1/177817 inviduals
153001578	c.1094T>A	p.Val365Glu	exon 3	VUS (X:153001578 T/A) frequency 1/177881 inviduals
153001580	c.1096A>T	p.Lys366*	exon 3	Pathogenic, identified in 3 ALD patients (181). Deleterious mutation.
153001581	c.1097A>G	p.Lys366Arg	exon 3	VUS (X:153001581 A/G) frequency 1/178004 inviduals
153001593	c.1109T>A	p.Leu370*	exon 3	Pathogenic, identified in 3 ALD patients (120). Deleterious mutation.
153001597	c.1113A>C	p.Glu371Asp	exon 3	VUS (X:153001597 A/C) frequency 1/178342 inviduals
153001598	c.1114A>T	p.Lys372*	exon 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001601	c.1117A>G	p.Lys373Glu	exon 3	Benign based on frequency 21/200035 individuals (X:153001601 A/G).
153001601	c.1117_19del 	p.Lys373del	exon 3	Pathogenic, identified in ALD patient (33).
153001603	c.1119G>C	p.Lys373Asn	exon 3	VUS (X:153001603 G/C) frequency 1/178411 inviduals.
153001604	c.1120G>A	p.Glu374Lys	exon 3	VUS (X:153001604 G/A) frequency 2/178403 inviduals.
153001609	c.1125G>A	p.Glu375Glu	exon 3	Synonymous (X:153001609 G/A).
153001610	c.1126G>C	p.Glu376Gln	exon 3	VUS (X:153001610 G/C) frequency 6/200118 inviduals.
153001618	c.1134G>A	p.Val378Val	exon 3	Synonymous (X:153001618 G/A).
153001619	c.1135_36insC	p.Ser379Thrfs*22 	exon 3	Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP expression in patient cells (7).
153001621	c.1137dup	p.Glu380Argfs*21 	exon 3	Pathogenic, identified in ALD patient (104). Deleterious mutation.
153001621	c.1137C>G	p.Ser379Arg	exon 3	Pathogenic, identified in ALD patient (33).
153001622	c.1138G>A	p.Glu380Lys	exon 3	VUS (X:153001622 G/A) frequency 1/178506 inviduals.
153001625	c.1141C>T	p.Arg381Cys	exon 3	VUS (X:153001625 C/T) frequency 5/200035 inviduals.
153001626	c.1142G>A	p.Arg381His	exon 3	VUS (X:153001626 G/A) frequency 6/200072 inviduals.
153001628	c.1144A>C	p.Thr382Pro	exon 3	Pathogenic, identified in 2 ALD patients (195).
153001634	c.1150G>A	p.Ala384Thr	exon 3	VUS (X:153001634 G/A) frequency 1/178617 inviduals.
153001635	c.1151C>G	p.Ala384Gly	exon 3	VUS (X:153001635 C/G) frequency 2/178634 inviduals.
153001636	c.1152C>T	p.Ala384Ala	exon 3	Synonymous (X:153001636 C/T).
153001640	c.1156A>G	p.Thr386Ala	exon 3	VUS (X:153001640 A/G) frequency 1/178645 inviduals.
153001640	c.1156A>T	p.Thr386Ser	exon 3	VUS (X:153001640 A/T) frequency 1/21583 inviduals.
153001639	c.1155del	p.Phe385Leufs*8	exon 3	Pathogenic, identified in ALD patient (90). Deleterious mutation.
153001643	c.1159del	p.Ile387Leufs*6	exon 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001647	c.1163_64insG	p.Arg389Profs*12 	exon 3	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
153001649	c.1165C>G	p.Arg389Gly	exon 3	Pathogenic, identified in 3 ALD patients (15, 60, 100).
153001649	c.1165C>T	p.Arg389Cys	exon 3	Pathogenic, identified in 6 ALD patients (58, 98).
153001649	c.[1165C>T; 1224+1GT>TG] 	p.[Arg389Cys; Val409fs*?] IVS 3 +	exon 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001650	c.1166G>A	p.Arg389His	exon 3	Pathogenic, identified in 25 ALD patients (13, 16, 22, 32, 60, 97, 111, 139, 141, 146, 178). Reduced (41% of control cells) ALDP in patient cells (139, 141).
153001655	c.1171_80del 	p.Leu391Argfs*16 	exon 3	Pathogenic, identified in 2 ALD patients (60). Deleterious mutation.
153001656	c.1172T>C	p.Leu391Pro	exon 3	Pathogenic, identified in ALD patient (68).
153001656	c.1172T>G	p.Leu391Arg	exon 3	VUS (X:153001656 T/G) frequency 1/178700 inviduals
153001658	c.1174C>G	p.Leu392Val	exon 3	Pathogenic, identified in 2 ALD patients (33, 88).
153001658	c.1174_81delinsAAT 	p.Leu392Asnfs*7	exon 3	Pathogenic, identified in ALD patient (130). Deleterious mutation.
153001663	c.1179A>C	p.Thr393Thr	exon 3	Synonymous (X:153001663 A/C).
153001663	c.1179_80del 	p.Ala394Glyfs*6	exon 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001664	c.1180del	p.Ala394Argfs*16 	exon 3	Pathogenic, identified in 3 ALD patients (120). Deleterious mutation.
153001666	c.1182G>A	p.Ala394Ala	exon 3	Synonymous (X:153001666 G/A).
153001667	c.1183del	p.Ala395Leufs*15 	exon 3	Pathogenic, identified in ALD patient (125). Deleterious mutation.
153001670	c.1186G>A	p.Ala396Thr	exon 3	Pathogenic, identified in 7 ALD patients (33, 60, 181). No detectable ALDP in patient cells (60).
153001671	c.1187C>T	p.Ala396Val	exon 3	Pathogenic, identified in ALD patient (189).
153001674	c.1190A>G	p.Asp397Gly	exon 3	VUS (X:153001674 A/G) frequency 1/178725 inviduals.
153001681	c.1197T>C	p.Ile399Ile	exon 3	Synonymous (X:153001681 T/C).
153001685	c.1201C>A	p.Arg401Arg	exon 3	Synonymous (X:153001685 C/A).
153001685	c.1201C>T	p.Arg401Trp	exon 3	Pathogenic, identified in 18 ALD patients (24, 29, 32, 33, 51, 87, 88, 90, 96, 100, 145, 154).
153001685	c.1201C>G	p.Arg401Gly	exon 3	Pathogenic, identified in 2 ALD patients (100, 154).
153001686	c.1202G>A	p.Arg401Gln	exon 3	Pathogenic, identified in 38 ALD patients (8, 15, 22, 29, 32, 33, 40, 47, 49, 60, 71, 72, 86, 88, 93, 98, 105, 125, 126, 150, 158). Normal ALDP level in patient cells (22, 32, 33, 49, 60, 72), but non-functional.
153001689	c.1205T>A	p.Ile402Asn	exon 3	Pathogenic, identified in 2 ALD patients (131). No detectable ALDP in patient cells (131).
153001694	c.1210T>C	p.Ser404Pro	exon 3	Pathogenic, identified in 3 ALD patients (59, 64, 132).
153001695	c.1211C>A	p.Ser404*	exon 3	Pathogenic, identified in ALD patient (98). Deleterious mutation.
153001695	c.1211C>T	p.Ser404Leu	exon 3	VUS (X:153001695 C/T) frequency 1/178707 inviduals.
153001696	c.1212_14del 	p.Ser405del	exon 3	Pathogenic, identified in ALD patient (84).
153001696	c.1212G>A	p.Ser404Ser	exon 3	Synonymous (X:153001696 G/A).
153001697	c.1213T>C	p.Ser405Pro	exon 3	Pathogenic, identified in ALD patient (137).
153001698	c.1214C>A	p.Ser405*	exon 3	Pathogenic, identified in ALD patient (145). Deleterious mutation.
153001699	c.1215G>A	p.Ser405Ser	exon 3	Synonymous (X:153001699 G/A).
153001703	c.1219A>T	p.Lys407*	exon 3	Pathogenic, identified in 2 ALD patients (33, 49). Deleterious mutation.
153001708	c.1224G>A	p.Val409fs*? 	exon 3	Pathogenic, identified in 2 ALD patients (13). Deleterious mutation.
153001709	c.1224+1GT>TG	p.Val409fs*? 	IVS 3	Pathogenic, identified in ALD patient (58). Deleterious mutation.
153001710	c.1224+2T>C	p.Val409fs*? 	IVS 3	Pathogenic, identified in ALD patient (64). Deleterious mutation.
153001710	c.1224+2T>G	p.Val409fs*? 	IVS 3	Pathogenic, identified in ALD patient (103). Deleterious mutation.
153001713	c.1224+5C>T  	-	IVS 3	VUS (X:153001713 C/T) frequency 1/178636 individuals.
153001773	c.1225-26G>T   	-	IVS 3	VUS (X:153001773 G/T) frequency 9/178416 inviduals.
153001790	c.1225-9C>T  	-	IVS 3	VUS (X:153001790 C/T) frequency 2/178534 individuals.
153001791	c.1225-8T>A  	-	IVS 3	VUS (X:153001791 T/A) frequency 1/178537 inviduals.
153001792	c.1225-7_1239del22 	p.Val409fs*? 	IVS 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001797	c.1225-2A>C	p.Val409fs*? 	IVS 3	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001797	c.1225-2A>G	p.Val409fs*? 	IVS 3	Pathogenic, identified in ALD patient (96). Deleterious mutation.
153001802	c.1228A>T	p.Thr410Ser	exon 4	VUS (X:153001802 A/T) frequency 4/178585 inviduals.
153001803	c.1229C>A	p.Thr410Lys	exon 4	VUS (X:153001803 C/A) frequency 1/178582 inviduals.
153001803	c.1229C>T	p.Thr410Met	exon 4	VUS (X:153001803 C/T) frequency 3/178582 inviduals.
153001804	c.1230G>A	p.Thr410Thr	exon 4	Synonymous (X:153001804 G/A).
153001811	c.1237G>A	p.Ala413Pro	exon 4	Pathogenic, identified in ALD patient (33).
153001811	c.1237G>C	p.Ala413Pro	exon 4	Pathogenic, identified in ALD patient (33).
153001812	c.1238C>G	p.Ala413Gly	exon 4	VUS (X:153001812 C/G) frequency 1/178591 inviduals.
153001813	c.1239T>C	p.Ala413Ala	exon 4	Synonymous (X:153001813 T/C).
153001818	c.1244A>G	p.Tyr415Cys	exon 4	Pathogenic, identified in ALD patient (84).
153001819	c.1245C>T	p.Tyr415Tyr	exon 4	Synonymous (X:153001819 C/T).
153001822	c.1248del	p.Ala417Profs*24 	exon 4	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001824	c.1250del	p.Arg418Glyfs*23 	exon 4	Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP in patient cells (7).
153001826	c.1252C>T	p.Arg418Trp	exon 4	Pathogenic, identified in 19 ALD patients (8, 15, 29, 33, 40, 58, 145, 177, 178, 191). Affects ALDP stability in patient cells (33, 58, 165).
153001827	c.1253G>A	p.Arg418Gln	exon 4	Status unknown (VUS), identified in ALD newborn screening (191), but also in 1/178560 inviduals (X:153001827 G/A).
153001829	c.1255G>A	p.Val419Met	exon 4	VUS (X:153001829 G/A) frequency 4/178589 inviduals.
153001829	c.1255G>C	p.Val419Leu	exon 4	VUS (X:153001829 G/C) frequency 1/178589 inviduals.
153001833	c.1259A>C	p.His420Pro	exon 4	Pathogenic, identified in ALD patient (104).
153001834	c.1260C>A	p.His420Gln	exon 4	VUS (X:153001834 C/A) frequency 7/178596 inviduals.
153001835	c.1261G>A	p.Glu421Lys	exon 4	VUS (X:153001835 G/A) frequency 1/178608 inviduals.
153001837	c.1263delG 	p.Met422Cysfs*19 	exon 4	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001841	c.1267T>A	p.Phe423Ile	exon 4	VUS (X:153001841 T/A) frequency 1/178615 inviduals.
153001842	c.1268T>C	p.Phe423Ser	exon 4	Pathogenic, identified in ALD patient (145).
153001844	c.1270C>T	p.Gln424*	exon 4	Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
153001844	c.1270delC 	p.Gln424Argfs*17 	exon 4	Pathogenic, identified in ALD patient (52). Deleterious mutation.
153001847	c.1273G>A	p.Val425Ile	exon 4	VUS (X:153001847 G/A).
153001853	c.1279_81del 	p.Glu427del	exon 4	Pathogenic, identified in ALD patient (49).
153001862	c.1288C>T	p.Gln430*	exon 4	Pathogenic, identified in ALD patient (49). Deleterious mutation.
153001862	c.[1288C>T; 1390C>T] 	p.[Gln430*; Arg464*]  exon 4 +	exon 4	Pathogenic, identified in ALD patient (33). Two deleterious mutations.
153001865	c.1291C>T	p.Arg431Cys	exon 4	VUS (X:153001865 C/T) frequency 1/178596 inviduals.
153001866	c.1292G>A	p.Arg431His	exon 4	VUS (X:153001866 G/A) frequency 2/178590 inviduals.
153001869	c.1295G>A	p.Cys432Tyr	exon 4	VUS (X:153001869 G/A) frequency 1/178586 inviduals.
153001873	c.1299C>T	p.His433His	exon 4	Synonymous (X:153001873 C/T).
153001878	c.1304A>G	p.Lys435Arg	exon 4	VUS (X:153001878 A/G) frequency 1/178568 inviduals.
153001889	c.1315G>T	p.Glu439*	exon 4	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
153001891	c.1317G>A	p.Glu439Glu	exon 4	Synonymous (X:153001891 G/A).
153001896	c.1322dupA 	p.Asp442Glyfs*114	exon 4	Pathogenic, identified in 3 ALD patients (32, 141). Deleterious mutation. No detectable ALDP in patient cells (32, 141).
153001900	c.1326C>G	p.Asp442Glu	exon 4	VUS (X:153001900 C/G) frequency 1/178469 inviduals.
153001900	c.1326C>T	p.Asp442Asp	exon 4	Synonymous (X:153001900 C/T).
153001901	c.1327G>A	p.Ala443Thr	exon 4	VUS (X:153001901 G/A) frequency 4/178453 inviduals.
153001904	c.1330C>T	p.Gln444*	exon 4	Pathogenic, identified in 3 ALD patients (32, 60). Deleterious mutation.
153001908	c.1334C>T	p.Ala445Val	exon 4	VUS (X:153001908 C/T) frequency 2/178358 inviduals
153001909	c.1335G>A	p.Ala445Ala	exon 4	Synonymous (X:153001909 G/A).
153001921	c.1347C>T	p.Thr449Thr	exon 4	Synonymous (X:153001921 C/T).
153001924	c.1350A>G	p.Ile450Met	exon 4	VUS (X:153001924 A/G) frequency 2/178260 inviduals.
153001928	c.1354C>T	p.Arg452Trp	exon 4	Benign, based on its frequency of 92/199674 inviduals (X:153001928 C/T).
153001929	c.1355G>T	p.Arg452Leu	exon 4	VUS (X:153001929 G/T) frequency 1/178072 inviduals.
153001929	c.1355G>A	p.Arg452Gln	exon 4	VUS (X:153001929 G/A) frequency 3/178072 inviduals.
153001932	c.1358delinsGA 	p.Ser453*	exon 4	Pathogenic, identified in ALD patient (58). Deleterious mutation.
153001933	c.1359delT 	p.Gly454Valfs*8	exon 4	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153001940	c.1366C>T	p.Arg456Cys	exon 4	VUS (X:153001940 C/T) frequency 2/177723 inviduals.
153001941	c.1367G>A	p.Arg456His	exon 4	VUS (X:153001941 G/A) frequency 7/177689 inviduals.
153001941	c.1367G>T	p.Arg456Leu	exon 4	VUS (X:153001941 G/T) frequency 1/177689 inviduals.
153001941	c.1367G>C	p.Arg456Pro	exon 4	VUS (X:153001941 G/C) frequency 1/177689 inviduals.
153001943	c.1369G>C	p.Val457Leu	exon 4	VUS (X:153001943 G/C) frequency 1/177679 inviduals.
153001946	c.1372G>T	p.Glu458*	exon 4	Pathogenic, identified in ALD patient (29). Deleterious mutation.
153001961	c.1387A>T	p.Ile463Phe	exon 4	VUS (X:153001961 A/T) frequency 1/176350 inviduals.
153001964	c.1390C>T	p.Arg464*	exon 4	Pathogenic, identified in 19 ALD patients (6, 32, 33, 47, 49, 59, 62, 64, 96, 105, 132, 141). Deleterious mutation. No detectable ALDP in patient cells (6, 32, 77, 141).
153001964	c.1390_91insA	p.Arg464Glnfs*92 	exon 4	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001965	c.1391G>A	p.Arg464Gln	exon 4	VUS (X:153001965 G/A) frequency 6/197263 inviduals.
153001965	c.1391G>C	p.Arg464Pro	exon 4	VUS (X:153001965 G/C) frequency 3/175733 inviduals.
153001968	c.1393+1G>A	p.Val425fs*92	IVS 4	Pathogenic, identified in ALD patient (135). Activation of cryptic spice site, confirmed by functional studies (135).
153001969	c.1393+2T>A	p.Phe426Argfs*92 	IVS 4	Pathogenic, identified in 6 ALD patients (159). Activation of cryptic spice site, confirmed by functional studies (159).
153002609	c.1394-2A>G	p.Gly465fs*? 	IVS 4	Pathogenic, identified in 4 ALD patients (32, 71, 75, 150). Activation of cryptic spice site, confirmed by functional studies (75).
153002613	c.1396C>T	p.Gln466*	exon 5	Pathogenic, identified in 3 ALD patients (13, 32, 158). Deleterious mutation. No detectable ALDP in patient cells (32).
153002616	c.1399G>A	p.Val467Met	exon 5	VUS (X:153002616 G/A) frequency 1/177603 inviduals.
153002616	c.[1399G>A; 1850G>A] 	p.[Val467Met; Arg617His]  exon 5 +	exon 8	Pathogenic, identified in ALD patient (33). p.Val467Met is a VUS; p.Arg617His is a true pathogenic mutation.
153002617	c.1400_05del 	p.Val467_Val468del 	exon 5	Pathogenic, identified in 2 ALD patients (143).
153002619	c.1402G>A	p.Val468Met	exon 5	VUS (X:153002619 G/A) frequency 1/177657 inviduals.
153002621	c.1404G>A	p.Val468Val	exon 5	Synonymous (X:153002621 G/A).
153002628	c.1411_12insA	p.Gln472Thrfs*84 	exon 5	Pathogenic, identified in 2 ALD patients (13). Deleterious mutation.
153002629	c.1412_13del 	p.Glu471Alafs*84 	exon 5	Pathogenic, identified in 2 ALD patients (13). Deleterious mutation.
153002630	c.1413A>G	p.Glu471Glu	exon 5	Synonymous (X:153002630 A/G).
153002631	c.1414dupC 	p.Gln472Profs*84 	exon 5	Pathogenic, identified in ALD patient (47). Deleterious mutation.
153002632	c.1415_16delAG 	p.Gln472Argfs*83 	exon 5	Pathogenic, identified in 139 ALD patients (1, 7, 8, 10, 13, 15, 16, 22, 24, 29, 32, 33, 36, 40, 43, 48,, 49, 53, 58, 59, 60, 62, 63, 64, 85, 86, 88, 90, 93, 100, 105, 108, 110, 119, 120, 125, 132, 145, 146, 158, 164, 169, 174, 178, 191). Deleterious mutation. No detectable ALDP in patient cells (7, 22, 32, 36, 53, 58, 60, 146).
153002633	c.1416_17del 	p.Gly473Aspfs*82 	exon 5	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002637	c.1420del	p.Ile474Serfs*84 	exon 5	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells(60).
153002639	c.1421T>C	p.Ile474Thr	exon 5	Pathogenic, identified in 4 ALD patients (33, 88, 125).
153002638	c.1422_26del 	p.Ile474Metfs*80 	exon 5	Pathogenic, identified in ALD patient (66). Deleterious mutation.
153002643	c.1426T>G	p.Cys476Gly	exon 5	VUS (X:153002643 T/G) frequency 1/177774 inviduals
153002645	c.1428C>A	p.Cys476*	exon 5	Pathogenic, identified in ALD patient (125). Deleterious mutation.
153002645	c.1428C>G	p.Cys476Trp	exon 5	VUS (X:153002645 C/G) frequency 1/177715 inviduals.
153002645	c.1428C>T	p.Cys476Cys	exon 5	Synonymous (X:153002645 C/T).
153002646	c.1429G>A	p.Glu477Lys	exon 5	VUS (X:153002646 G/A) frequency 4/177731 inviduals.
153002646	c.1429G>T	p.Glu477*	exon 5	Pathogenic, identified in 4 ALD patients (8, 15, 33). Deleterious mutation.
153002647	c.1430del	p.Glu477Glyfs*81 	exon 5	Pathogenic, identified in 3 ALD patients (91, 100). Deleterious mutation.
153002653	c.1436del	p.Ile479Thrfs*79 	exon 5	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002658	c.1441A>T	p.Ile481Phe	exon 5	Pathogenic, identified in ALD patient (100).
153002658	c.1441A>G	p.Ile481Val	exon 5	VUS (X:153002658 A/G) frequency 1/177634 inviduals.
153002660	c.1443C>T	p.Ile481Ile	exon 5	Synonymous (X:153002660 C/T).
153002661	c.1444G>A	p.Val482Ile	exon 5	VUS (X:153002661 G/A) frequency 8/199256 inviduals.
153002662	c.1445T>A	p.Val482Asp	exon 5	Pathogenic, identified in ALD patient (142).
153002668	c.1451C>G	p.Pro484Arg	exon 5	Pathogenic, identified in 5 ALD patients (3).
153002669	c.1452C>G	p.Pro484Pro	exon 5	Synonymous (X:153002669 C/G).
153002671	c.1454C>A	p.Ser485*	exon 5	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002672	c.1455A>C	p.Ser485Ser	exon 5	Synonymous (X:153002672 A/C).
153002672	c.1455_59delinsGGGA	p.Glu487Argfs*71 	exon 5	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002673	c.1456G>A	p.Gly486Arg	exon 5	VUS (X:153002673 G/A) frequency 5/176936 inviduals.
153002679	c.1462_63insTGG	p.Val488_Val489insVal	exon 5	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153002684	c.1467G>A	p.Val489Val	exon 5	Synonymous (X:153002684 G/A).
153002686	c.1469_71del 	p.Val490del	exon 5	Pathogenic, identified in ALD patient (33).
153002687	c.1470_71insGTG	p.Val490_Ala491insVal	exon 5	Pathogenic, identified in ALD patient (7). No detectable ALDP in patient cells (7).
153002687	c.1470_72dup 	p.Ala491dup	exon 5	Pathogenic, identified in ALD patient (33).
153002694	c.1477_1488+11del	p.Leu493_Arg496del 	exon 5	Pathogenic, identified in ALD patient (108).
153002695	c.1478T>C	p.Leu493Pro	exon 5	Pathogenic, identified in 2 ALD patients (33, 88).
153002698	c.1481del	p.Asn494Thrfs*64 	exon 5	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002704	c.1487G>C	p.Arg496Thr	exon 5	VUS (X:153002704 G/C) frequency 1/174592 inviduals.
153002706	c.1488+1G>A	p.Val497fs*? 	IVS 5	Pathogenic, identified in 2 ALD patients (33, 40). Deleterious mutation.
153002708	c.1488+3A>G	p.Val497fs*? 	IVS 5	Pathogenic, identified in 4 ALD patients (32). Deleterious mutation.
153005536	c.1489-10delC  	-	IVS 5	Benign, based on its frequency of 1374/197671 inviduals (X:153005536 GC/G). East-Asian specific polymorphism (1286/13873 inviduals) confirmed by pedigree analysis (68).
153005537	c.1489-9C>T  	-	IVS 5	VUS (X:153005537 C/T) frequency 1/175888 individuals.
153005540	c.1489-6delC   	-	IVS 5	Benign, based on its frequency of 1374/197671 inviduals (X:153005536 GC/G). East-Asian specific polymorphism (1286/13873 inviduals) confirmed by pedigree analysis (68).
153005544	c.1489-2A>G	p.Val497fs*? 	IVS 5	Pathogenic, identified in ALD patient (198). Deleterious mutation.
153005545	c.1489-1_1489delinsTT	p.Val497fs*? 	IVS 5	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005546	c.1489G>A	p.Val497Met	exon 6	VUS (X:153005546 G/A) frequency 1/176603 inviduals
153005554	c.1497_1505del 	p.Glu499_His502delinsAsp 	exon 6	Pathogenic, identified in ALD patient (105).
153005556	c.1499G>T	p.Gly500Val	exon 6	Pathogenic, identified in ALD patient (33).
153005558	c.1501A>C	p.Met501Leu	exon 6	Pathogenic, identified in ALD patient (60). Normal ALDP level in patient cells (60), but non-functional
153005559	c.1502del	p.Met501Serfs*57 	exon 6	Pathogenic, identified in ALD patient (197). Deleterious mutation.
153005562	c.1505_06insC	p.Leu503Serfs*53 	exon 6	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005565	c.1505_10del 	p.Leu503_Leu504del 	exon 6	Pathogenic, identified in ALD patient (58).
153005562	c.1508T>C	p.Leu503Pro	exon 6	Pathogenic, identified in 2 ALD patients (63, 146).
153005565	c.1508_09insC	p.Leu504Alafs*52 	exon 6	Pathogenic, identified in ALD patient (27). Deleterious mutation.
153005572	c.1514T>C	p.Ile505Thr	exon 6	Pathogenic, identified in ALD patient (33).
153005571	c.1515C>G	p.Ile505Met	exon 6	Pathogenic, identified in ALD patient (32, 58). Affects ALDP stability in patient cells (32, 58).
153005572	c.1515_19delinsGCA 	p.Ile505Metfs*50 	exon 6	Pathogenic, identified in ALD patient (60). Deleterious mutation.
153005576	c.1519G>A	p.Gly507Ser	exon 6	Pathogenic, identified in 3 ALD patients (32).
153005577	c.1520G>A	p.Gly507Asp	exon 6	Pathogenic, identified in 2 ALD patients (68, 88).
153005577	c.1520G>T	p.Gly507Val	exon 6	Pathogenic, identified in ALD patient (24).
153005578	c.1521C>T	p.Gly507Gly	exon 6	Synonymous (X:153005578 C/T).
153005580	c.1523C>T	p.Pro508Leu	exon 6	Pathogenic, identified in ALD patient (93).
153005583	c.1526A>G	p.Asn509Ser	exon 6	VUS (X:153005583 A/G) frequency 1/177654 inviduals.
153005583	c.1526A>T	p.Asn509Ile	exon 6	Pathogenic, identified in 4 ALD patients (33, 64, 132, 137).
153005585	c.1528G>A	p.Gly510Ser	exon 6	Pathogenic, identified in 2 ALD patients (33, 100).
153005586	c.1529G>A	p.Gly510Asp	exon 6	Pathogenic, identified in 5ALD patients (33, 59, 64, 132, 137).
153005588	c.1531T>C	p.Cys511Arg	exon 6	Pathogenic, identified in ALD patient (33).
153005589	c.1532G>A	p.Cys511Tyr	exon 6	Pathogenic, identified in 2 ALD patients (33, 137).
153005590	c.1533C>T	p.Cys511Cys	exon 6	Synonymous (X:153005590 C/T).
153005590	c.1533C>A	p.Cys511*	exon 6	Pathogenic, identified in 2 ALD patients (33, 49). Deleterious mutation.
153005590	c.1533C>G	p.Cys511Trp	exon 6	Pathogenic, identified in ALD patient (137).
153005591	c.1534G>T	p.Gly512Cys	exon 6	Pathogenic, identified in ALD patient (47).
153005591	c.1534G>A	p.Gly512Ser	exon 6	Pathogenic, identified in 32 ALD patients (7, 13, 23, 27, 33, 53, 57, 58, 76, 88, 93, 100, 108, 121, 124, 153, 154, 158, 178, 181, 185, 191). No detectable ALDP in patient cells (7, 23, 53, 58). Mutation results in reduced ATPase activity (194).
153005593	c.1536C>G	p.Gly512Gly	exon 6	Synonymous (X:153005593 C/G).
153005594	c.1537A>C	p.Lys513Gln	exon 6	Pathogenic, identified in 2 ALD patients (33, 69).
153005595	c.1538A>G	p.Lys513Arg	exon 6	Pathogenic, identified in 2 ALD patients (58, 125). No detectable ALDP in patient cells (58).
153005597	c.1540A>C	p.Ser514Arg	exon 6	Pathogenic, identified in 5 ALD patienst (63, 145).
153005597	c.1540A>G	p.Ser514Gly	exon 6	Pathogenic, identified in 2 ALD patienst (32).
153005598	c.1541G>T	p.Ser514Ile	exon 6	Pathogenic, identified in 2 ALD patients (88).
153005598	c.1541G>A	p.Ser514Asn	exon 6	Pathogenic, identified in 2 ALD patients (58, 145). Affects ALDP stability in patient cells (58).
153005601	c.1544C>A	p.Ser515Tyr	exon 6	Pathogenic, identified in ALD patient (125).
153005601	c.1544C>T	p.Ser515Phe	exon 6	Pathogenic, identified in 11 ALD patients (8, 51, 112, 179).
153005604	c.1547T>C	p.Leu516Pro	exon 6	Pathogenic, identified in 5 ALD patients (33, 58, 71, 150). No detectable ALDP in patient cells (58).
153005605	c.1548G>A	p.Leu516Leu	exon 6	Synonymous (X:153005605 G/A) frequency 18810/199236 individuals.
153005608	c.1551C>T	p.Phe517Phe	exon 6	Synonymous (X:153005608 C/T).
153005608	c.1551del	p.Arg518Glyfs*40 	exon 6	Pathogenic, identified in 2 ALD patients (6, 33). Deleterious mutation.
153005609	c.1552C>G	p.Arg518Gly	exon 6	Pathogenic, identified in 4 ALD patients (59, 64, 132, 137).
153005609	c.1552C>T	p.Arg518Trp	exon 6	Pathogenic, identified in 19 ALD patients (6, 7, 32, 33, 53, 58, 88, 90, 125, 133, 137). No detectable ALDP in patient cells (7, 58).
153005610	c.1553G>A	p.Arg518Gln	exon 6	Pathogenic, identified in 47 ALD patients (9, 24, 32, 33, 48, 49, 53, 58, 59, 60, 64, 88, 90, 96, 100, 105, 108, 120, 132, 137, 154, 181, 191). No detectable ALDP in patient cells (9, 32, 49, 53, 58, 60).
153005616	c.1559T>A	p.Leu520Gln	exon 6	Pathogenic, identified in 5 ALD patients (54, 59, 64, 132, 137).
153005621	c.1564G>A	p.Gly522Arg	exon 6	Pathogenic, identified in 2 ALD patients (7, 58). No detectable ALDP in patient cells (7, 58).
153005624	c.1567C>T	p.Leu523Phe	exon 6	Pathogenic, identified in ALD patient (96).
153005625	c.1568T>C	p.Leu523Pro	exon 6	Pathogenic, identified in ALD patient (33).
153005627	c.1570T>C	p.Trp524Arg	exon 6	Pathogenic, identified in ALD patient (33).
153005628	c.1571G>A	p.Trp524*	exon 6	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153005630	c.1573C>G	p.Pro525Ala	exon 6	Pathogenic, identified in ALD patient (33).
153005630	c.1573C>T	p.Pro525Ser	exon 6	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153005638	c.1581C>T	p.Tyr527Tyr	exon 6	Synonymous (X:153005638 C/T).
153005638	c.1581C>A	p.Tyr527*	exon 6	Pathogenic, identified in ALD patient (105). Deleterious mutation.
153005639	c.1582G>A	p.Gly528Ser	exon 6	Benign, (X:153005639 G/A) frequency 8/199702 inviduals, confirmed by biochemical testing (144).
153005642	c.1585G>A	p.Gly529Ser	exon 6	Pathogenic, identified in ALD patient (38).
153005642	c.1585_87del 	p.Gly529del	exon 6	Pathogenic, identified in 2 ALD patients (4, 105).
153005642	c.1585delG 	p.Gly529Valfs*29 	exon 6	Pathogenic, identified in 2 ALD patients (21, 62). Deleterious mutation.
153005643	c.1586_90del 	p.Gly529Valfs*25 	exon 6	Pathogenic, identified in ALD patient (49). Deleterious mutation. No detectable ALDP in patient cells (49).
153005643	c.1586G>A	p.Gly529Asp	exon 6	Pathogenic, identified in 2 ALD patients (33).
153005645	c.1588G>A	p.Val530Met	exon 6	VUS (X:153005645 G/A) frequency 1/178126 inviduals
153005649	c.1592_93insT	p.Tyr532Leufs*24 	exon 6	Pathogenic, identified in ALD patient (38). Deleterious mutation.
153005654	c.1597A>C	p.Lys533Gln	exon 6	Status unresolved, identified in newborn screening (181). Functional testing pending.
153005654	c.1597A>G	p.Lys533Glu	exon 6	Pathogenic, identified in 2 ALD patients (33, 60). No detectable ALDP in patient cells (60).
153005655	c.1598A>G	p.Lys533Arg	exon 6	Pathogenic, identified in ALD patient (183).
153005655	c.1598_99insA	p.Pro534Alafs*22 	exon 6	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005656	c.1599G>T	p.Lys533Asn	exon 6	Pathogenic, identified in ALD patient (84).
153005656	c.1599delG 	p.Lys533Asnfs*25 	exon 6	Pathogenic, identified in ALD patient (49). Deleterious mutation. No detectable ALDP in patient cells (49).
153005657	c.1600C>T	p.Pro534Ser	exon 6	Pathogenic, identified in 2 ALD patients (33, 191).
153005658	c.1601C>T	p.Pro534Leu	exon 6	Pathogenic, identified in 2 ALD patients (23, 191, 200</a). No detectable ALDP in patient cells (23).
153005658	c.1601C>G	p.Pro534Arg	exon 6	Pathogenic, identified in 5 ALD patients (67, 86, 93, 132, 137).
153005660	c.1603_04del 	p.Pro535Thrfs*20 	exon 6	Pathogenic, identified in 3 ALD patients (59, 64, 132). Deleterious mutation.
153005660	c.1603_1991del 	p.Pro535Glufs*69 	exon 6	Pathogenic, identified in 7 ALD patients (16, 32). Deleterious mutation. No detectable ALDP in patient cells (32).
153005664	c.1607C>A	p.Pro536His	exon 6	Pathogenic, identified in ALD patient (84).
153005666	c.1609C>T	p.Gln537*	exon 6	Pathogenic, identified in ALD patient (96). Deleterious mutation.
153005668	c.1611G>C	p.Gln537His	exon 6	VUS (X:153005668 G/C) frequency 2/178177 inviduals.
153005669	c.1612C>T	p.Arg538Cys	exon 6	VUS (X:153005669 C/T) frequency 1/178116 inviduals.
153005670	c.1613G>A	p.Arg538His	exon 6	VUS (X:153005670 G/A).
153005672	c.1615A>C	p.Met539Leu	exon 6	VUS (X:153005672 A/C) frequency 3/199708 inviduals.
153005672	c.1615A>T	p.Met539Leu	exon 6	VUS (X:153005672 A/T) frequency 1/178110 inviduals.
153005674	c.1617G>A	p.Met539Ile	exon 6	VUS (X:153005674 G/A) frequency 1/178094 inviduals.
153005676	c.1619T>C	p.Phe540Ser	exon 6	Pathogenic, identified in ALD patient (24).
153005676	c.1619T>G	p.Phe540Cys	exon 6	Pathogenic, identified in ALD patient (96).
153005677	c.1620C>G	p.Phe540Leu	exon 6	Status unknown (VUS), identified in ALD newborn screening (191).
153005677	c.1620C>T	p.Phe540Phe	exon 6	Synonymous (X:153005677 C/T).
153005681	c.1624_26del 	p.Ile542del	exon 6	Pathogenic, identified in ALD patient (68).
153005684	c.1627C>T	p.Pro543Ser	exon 6	Pathogenic, identified in ALD patient (186).
153005685	c.1628C>T	p.Pro543Leu	exon 6	Pathogenic, identified in 36 ALD patients (27, 29, 32, 33, 40, 49, 60, 65, 114, 139, 141, 145, 158, 178). No detectable ALDP in patient cells (32, 49, 60, 139, 141).
153005685	c.1628delC 	p.Pro543Argfs*15 	exon 6	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005685	c.1628_34dup 	p.Arg545serfs*13 	exon 6	Pathogenic, identified in 2 ALD patients (32, 49). Deleterious mutation. No detectable ALDP in patient cells (32).
153005686	c.1629G>A	p.Pro543Pro	exon 6	Synonymous (X:153005686 G/A).
153005687	c.1630C>A	p.Gln544Lys	exon 6	Pathogenic, identified in ALD patient (58). Affects ALDP stability in patient cells (58).
153005688	c.1631A>G	p.Gln544Arg	exon 6	Pathogenic, identified in 6 ALD patients (9, 24, 33, 88, 90). Normal ALDP level in patient cells (9), but non-functional
153005690	c.1633A>T	p.Arg545Trp	exon 6	Pathogenic, identified in ALD patient (53).
153005691	c.1634G>A	p.Arg545Lys	exon 6	VUS (X:153005691 G/A) frequency 1/177632 inviduals.
153005692	c.1634+1G>A	p.Pro546fs*? 	IVS 6	Pathogenic, identified in 4 ALD patients (6, 49, 60, 132). Deleterious mutation.
153005692	c.1634+1G>C	p.Pro546fs*? 	IVS 6	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005695	c.1634+4A>G  	-	IVS 6	VUS (X:153005695 A/G) frequency 1/177483 individuals.
153005696	c.1634+5G>C  	-	IVS 6	VUS (X:153005696 G/C) frequency 1/177317 individuals.
153006013	c.1635-16_1645delins CACAGACATGTAGGGC	p.Pro546fs*? 	IVS 6	Pathogenic, identified in ALD patient (181). Deleterious mutation.
153006022	c.1635-6C>T  	-	IVS 6	VUS (X:153006022 C/T) frequency 3/199784 inviduals.
153006025	c.1635-3C>G	p.Pro546fs*? 	IVS 6	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153006026	c.1635-2A>G	p.Pro546fs*? 	IVS 6	Pathogenic, identified in 5 ALD patients (11, 33). Deleterious mutation. No detectable ALDP in patient cells (33) due to splicing defect (11).
153006033	c.1640A>G	p.Tyr547Cys	exon 7	Pathogenic, identified in 3 ALD patients (33, 104, 124). No detectable ALDP in patient cells (104).
153006046	c.1653C>T	p.Gly551Gly	exon 7	Synonymous (X:153006046 C/T). Variant is found in a segmental duplication region (SEGDUP), which may indicate a low-quality site. See (Pseudogenes & Mutation analysis).
153006046	c.1653insG 	p.Ser552fs*3 	exon 7	Pathogenic, identified in ALD patient (100). Deleterious mutation.
153006047	c.1654T>C	p.Ser552Pro	exon 7	Pathogenic, identified in 2 ALD patients (28, 33).
153006050	c.1657C>G	p.Leu553Val	exon 7	Pathogenic, identified in ALD patient (33).
153006054	c.1661G>A	p.Arg554His	exon 7	Pathogenic, identified in 47 ALD patients (28, 29, 32, 33, 49, 52, 58, 59, 60, 62, 63, 64, 87, 88, 97, 100, 102, 107, 108, 111, 120, 132, 137, 145, 178, 191). No detectable (1% of controls (97)) ALDP in patient cells (32, 49, 58, 60, 97, 102).
153006056	c.1663G>A	p.Asp555Asn	exon 7	Pathogenic, identified in ALD patient (52).
153006059	c.1666C>T	p.Gln556*	exon 7	Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
153006060	c.1667A>G	p.Gln556Arg	exon 7	Pathogenic, identified in 5 ALD patients (40, 59, 64, 132, 137).
153006063	c.1670T>C	p.Val557Ala	exon 7	Status unknown (VUS), identified in ALD newborn screening (191).
153006063	c.1670_71del 	p.Val557Aspfs*43 	exon 7	Pathogenic, identified in ALD patient (49). Deleterious mutation.
153006066	c.1673T>C	p.Ile558Thr	exon 7	Pathogenic, identified in ALD patient (72). Normal ALDP level in patient cells (72).
153006069	c.1676A>G	p.Tyr559Cys	exon 7	Pathogenic, identified in 4 ALD patients (32, 33).
153006070	c.1677C>G	p.Tyr559*	exon 7	Pathogenic, identified in ALD patient (122). Deleterious mutation.
153006071	c.1678C>T	p.Pro560Ser	exon 7	Pathogenic, identified in ALD patient (49).
153006072	c.1679C>T	p.Pro560Leu	exon 7	Pathogenic, identified in 39 ALD patients (4, 7, 24, 32, 33, 49, 71, 86, 88, 90, 93, 96, 100, 108, 111, 136, 145, 150, 158, 165). Affects ALDP stability in patient cells (7, 32, 33, 49).
153006072	c.1679C>G	p.Pro560Arg	exon 7	Pathogenic, identified in ALD patient (7). No detectable ALDP in patient cells (7).
153006073	c.1680G>A	p.Pro560Pro	exon 7	Synonymous (X:153006073 G/A).
153006075	c.1682A>T	p.Asp561Val	exon 7	Pathogenic, identified in 3 ALD patients (60). No detectable ALDP in patient cells (60).
153006087	c.1694A>G	p.Asp565Gly	exon 7	VUS (X:153006087 A/G) frequency 1/178467 inviduals.
153006090	c.1697T>A	p.Met566Lys	exon 7	Pathogenic, identified in 2 ALD patients (13). No detectable ALDP in patient cells (33).
153006090	c.1697T>C	p.Met566Thr	exon 7	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153006092	c.1699C>T	p.Gln567*	exon 7	Pathogenic, identified in 2 ALD patients (33, 60). Deleterious mutation.
153006107	c.1714T>C	p.Ser572Pro	exon 7	Status unknown (VUS), identified in ALD newborn screening (191).
153006107	c.1714_25del 	p.Ser572_Asp575del 	exon 7	Pathogenic, identified in 2 ALD patients (81, 104).
153006108	c.1715C>T	p.Ser572Leu	exon 7	VUS (X:153006108 C/T) frequency 1/178412 inviduals.
153006108	c.1715C>A	p.Ser572*	exon 7	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153006110	c.1717delG 	p.Glu573Serfs*63 	exon 7	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153006113	c.1720C>T	p.Gln574*	exon 7	Pathogenic, identified in ALD patient (53, 58). Deleterious mutation. No detectable ALDP in patient cells (53, 58).
153006119	c.1726dup	p.Leu576Profs*25 	exon 7	Pathogenic, identified in ALD patient (120). Deleterious mutation.
153006120	c.1727T>C	p.Leu576Pro	exon 7	Pathogenic, identified in 4 ALD patients (93, 98, 132, 137).
153006122	c.1729G>T	p.Glu577*	exon 7	Pathogenic, identified in ALD patient (100). Deleterious mutation.
153006124	c.1731del	p.Ala578Profs*58 	exon 7	Pathogenic, identified in ALD patient (105). Deleterious mutation.
153006125	c.1732G>A	p.Ala578Thr	exon 7	VUS (X:153006125 G/A) frequency 6/178388 inviduals.
153006127	c.1734C>G	p.Ala578Ala	exon 7	Synonymous (X:153006127 C/G).
153006136	c.1743C>T	p.Asp581Asp	exon 7	Synonymous (X:153006136 C/T).
153006137	c.1744G>T	p.Val582Phe	exon 7	VUS (X:153006137 G/T).
153006139	c.1746del	p.Val583Cysfs*53 	exon 7	Pathogenic, identified in 2 ALD patients (27, 158). Deleterious mutation.
153006140	c.1747G>A	p.Val583Met	exon 7	Status unknown (VUS), identified in ALD newborn screening (191).
153006140	c.1747_1759del 	p.Val583Thrfs*49 	exon 7	Pathogenic, identified in ALD patient (145). Deleterious mutation.
153006141	c.1748T>C	p.Val583Ala	exon 7	Benign, based on its frequency of 26/169917 inviduals (X:153006141 T/C).
153006141	c.1748T>G	p.Val583Gly	exon 7	Pathogenic, identified in ALD patient (33).
153006143	c.1750C>T	p.His584Tyr	exon 7	VUS (X:153006143 C/T) frequency 1/178270 inviduals
153006147	c.1754T>C	p.Leu585Pro	exon 7	Pathogenic, identified in ALD patient (68).
153006148	c.1755del	p.His586Thrfs*50 	exon 7	Pathogenic, identified in ALD patient (62). Deleterious mutation.
153006152	c.1759_61dup 	p.His587dup	exon 7	Pathogenic, identified in ALD patient (125).
153006152	c.1759_70del12 	p.His587_Gln590del 	exon 7	Pathogenic, identified in ALD patient (24).
153006158	c.1765del	p.Leu589Cysfs*47 	exon 7	Pathogenic, identified in ALD patient (49). Deleterious mutation.
153006161	c.1768C>T	p.Gln590*	exon 7	Pathogenic, identified in 8 ALD patients (20, 88, 176). Deleterious mutation.
153006162	c.1769A>T	p.Gln590Leu	exon 7	VUS (X:153006162 A/T) frequency 2/178017 inviduals.
153006164	c.1771del	p.Arg591Glyfs*45 	exon 7	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153006164	c.1771C>T	p.Arg591Trp	exon 7	Pathogenic, identified in 8 ALD patients (24, 32, 33, 53, 72, 161). Normal ALDP level in patient cells (53), but non-functional.
153006165	c.1772G>T	p.Arg591Leu	exon 7	Pathogenic, identified in 3 ALD patients (88, 145).
153006165	c.1772G>C	p.Arg591Pro	exon 7	Pathogenic, identified in 3 ALD patients (44, 49, 105). No detectable ALDP expression in patient cells (49).
153006165	c.1772G>A	p.Arg591Gln	exon 7	Pathogenic, identified in 21 ALD patients (22, 32, 33, 78, 98, 108, 145, 175, 191). Normal ALDP level in patient cells (22, 33), but non-functional (33).
153006173	c.1780G>C	p.Gly594Arg	exon 7	Pathogenic, identified in 2 ALD patients (33, 83).
153006174	c.1780+1G>A	p.Trp595fs*? 	IVS 7	Pathogenic, identified in 2 ALD patients (7, 53). Deleterious mutation.
153006175	c.1780+2T>G	p.Trp595fs*? 	IVS 7	Pathogenic, identified in 8 ALD patients (33, 38, 58, 71, 118, 150, 158). No detectable ALDP in patient cells (58) due to splicing defect (118).
153006177	c.1780+4G>A  	-	IVS 7	Benign, based on its frequency of 41/199340 inviduals (X:153006177 G/A).
153008436	c.1781-5C>G  	-	IVS 7	Benign, based on its frequency of 12/165244 inviduals (X:153008436 C/G).
153008439	c.1781-2A>G	p.Trp595fs*? 	IVS 7	Pathogenic, identified in 3 ALD patients (32, 33). Deleterious mutation. No detectable ALDP in patient cells (32).
153008440	c.1781-1G>A	p.Trp595fs*? 	IVS 7	Pathogenic, identified in ALD patient (96). Deleterious mutation.
153008440	c.1781-1G>T	p.Trp595fs*? 	IVS 7	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008443	c.1783T>C	p.Trp595Arg	exon 8	Pathogenic, identified in ALD patient (88).
153008444	c.1784G>A	p.Trp595*	exon 8	Pathogenic, identified in 2 ALD patients (33, 90). Deleterious mutation.
153008445	c.1785G>A	p.Trp595*	exon 8	Pathogenic, identified in 4 ALD patients (24, 59, 64, 132). Deleterious mutation.
153008450	c.1790C>G	p.Ala597Gly	exon 8	Reported in ExAC (X:153008450 C/G) as a VUS. Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153008451	c.1791_92del 	p.Met598Valfs*2	exon 8	Pathogenic, identified in ALD patient (6). Deleterious mutation. No detectable ALDP in patient cells (58).
153008452	c.1792A>G	p.Met598Val	exon 8	VUS (X:153008452 A/G) frequency 7/174488 inviduals.
153008454	c.1794G>T	p.Met598Ile	exon 8	VUS (X:153008454 G/T).
153008462	c.1802G>A	p.Trp601*	exon 8	Pathogenic, identified in 9 ALD patients (27, 33, 53, 79, 100, 154). Deleterious mutation. No detectable ALDP in patient cells (53).
153008463	c.1803del	p.Trp601*	exon 8	Pathogenic, identified in ALD newborn screening (191). Deleterious mutation.
153008463	c.1803G>A	p.Trp601*	exon 8	Pathogenic, identified in 3 ALD patients (33, 77, 88). Deleterious mutation.
153008464	c.1804A>T	p.Lys602*	exon 8	Pathogenic, identified in ALD patient (93). Deleterious mutation.
153008470	c.1810G>A	p.Val604Ile	exon 8	Benign, based on its frequency of 111/179305 inviduals (X:153008470 G/A).
153008474	c.1814T>A	p.Leu605Gln	exon 8	Pathogenic, identified in 4 ALD patients (59, 64, 132, 137).
153008474	c.1814T>C	p.Leu605Pro	exon 8	Pathogenic, identified in ALD patient (33).
153008475	c.1815G>C	p.Leu605Leu	exon 8	Synonymous (X:153008475 G/C).
153008476	c.1816T>C	p.Ser606Pro	exon 8	Pathogenic, identified in 7 ALD patients (7, 33, 71, 72, 96, 100, 150). No detectable ALDP in patient cells (72).
153008476	c.1816T>G	p.Ser606Ala	exon 8	Pathogenic, identified in ALD patient (32).
153008477	c.1817C>T	p.Ser606Leu	exon 8	Pathogenic, identified in 28 ALD patients (6, 13, 22, 24, 33, 46, 49, 52, 57, 58, 59, 60, 64, 97, 100, 132, 137, 178, 180). Reduced (25% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, detectable ALDP by immunofluorescence (22, 33, 49, 60). Mutation affects ATP-binding capacity of ALDP (194).
153008478	c.1818G>A	p.Ser606Ser	exon 8	Synonymous (X:153008478 G/A).
153008478	c.1818G>C	p.Ser606Ser	exon 8	Synonymous (X:153008478 G/C).
153008480	c.1820del	p.Gly607Valfs*29 	exon 8	Pathogenic, identified in ALD patient (6). Deleterious mutation. No detectable ALDP in patient cells (6).
153008480	c.1820_23del 	p.Gly607Alafs*28 	exon 8	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008480	c.1820G>A	p.Gly607Asp	exon 8	Pathogenic, identified in ALD patient (52, 58). Normal ALDP level in patient cells (58), but non-functional.
153008482	c.1822G>A	p.Gly608Ser	exon 8	Pathogenic, identified in 3 ALD patients (58, 62, 105).
153008483	c.1823G>A	p.Gly608Asp	exon 8	Reported in ALD male (48), but considering its frequency of 306/36626 inviduals (X:153008483 G/A) this is not a pathogenic variant.
153008485	c.1825G>A	p.Glu609Lys	exon 8	Pathogenic, identified in 29 ALD patients (15, 16, 32, 33, 49, 60, 62, 72, 88, 90, 97, 141, 146). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 49, 60, 72, 141, 146).
153008486	c.1826A>G	p.Glu609Gly	exon 8	Pathogenic, identified in 3 ALD patients (16, 97, 141). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 49, 60, 72, 141, 146).
153008492	c.1832A>G	p.Gln611Arg	exon 8	Pathogenic, identified in ALD patient (33).
153008493	c.1833G>C	p.Gln611His	exon 8	Pathogenic, identified in ALD patient (33).
153008498	c.1838T>A	p.Ile613Asn	exon 8	Pathogenic, identified in ALD patient (33).
153008499	c.1839C>T	p.Ile613Ile	exon 8	Synonymous (X:153008499 C/T).
153008500	c.1840G>A	p.Gly614Ser	exon 8	VUS (X:153008500 G/A) frequency 3/21806 inviduals.
153008500	c.1840G>C	p.Gly614Arg	exon 8	Pathogenic, identified in ALD patient (88).
153008506	c.1846G>A	p.Ala616Thr	exon 8	Pathogenic, identified in 8 ALD patients (32, 97, 141). Reduced (4% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 141).
153008507	c.1847C>A	p.Ala616Asp	exon 8	Pathogenic, identified in ALD patient (90).
153008507	c.1847C>T	p.Ala616Val	exon 8	Pathogenic, identified in ALD patient (29).
153008509	c.1849C>A	p.Arg617Ser	exon 8	Pathogenic, identified in ALD patient (92).
153008509	c.1849C>G	p.Arg617Gly	exon 8	Pathogenic, identified in 10 ALD patients (15, 33, 59, 64, 67, 86, 93, 132, 137).
153008509	c.1849C>T	p.Arg617Cys	exon 8	Pathogenic, identified in 30 ALD patients (6, 15, 16, 32, 33, 49, 58, 59, 60, 64, 86, 88, 93, 132, 137, 145, 178). No detectable ALDP in patient cells (32, 49, 58).
153008509	c.1849del	p.Arg617Alafs*19 	exon 8	Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153008510	c.1850del	p.Arg617Profs*19 	exon 8	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008510	c.1850G>A	p.Arg617His	exon 8	Pathogenic, identified in 46 ALD patients (6, 13, 17, 22, 32, 33, 49, 57, 58, 60, 62, 74, 87, 88, 96, 100, 125, 145, 147, 154, 178). No detectable ALDP in patient cells (22, 33, 49, 58, 60, 147).
153008518	c.1858T>C	p.Tyr620His	exon 8	Pathogenic, identified in 2 ALD patients (88, 99).
153008519	c.1859del	p.Tyr620Serfs*16 	exon 8	Pathogenic, identified in 2 ALD patients (80). Deleterious mutation.
153008519	c.1859A>G	p.Tyr620Cys	exon 8	Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153008520	c.1860C>G	p.Tyr620*	exon 8	Pathogenic, identified in ALD patient (58). Deleterious mutation.
153008522	c.1862A>T	p.His621Leu	exon 8	Status unknown (VUS), identified in ALD newborn screening (191).
153008522	c.1862dup	p.His621Glnfs*10 	exon 8	Pathogenic, identified in ALD patient (58). Deleterious mutation.
153008526	c.1865+1G>A	p.Pro623fs*? 	IVS 8	Pathogenic, identified in 2 ALD patients (33, 152). Reduced (<1% of control cells) ALDP in patient cells due to splicing defect (152).
153008660	c.1866-15G>A 	p.Pro623fs*? 	IVS 8	Pathogenic, identified in 3 ALD patients (32).
153008665	c.1866-10G>A 	p.Pro623fs*? 	IVS 8	Pathogenic, identified in 26 ALD patients (11, 30, 32, 33, 58, 72, 100, 125, 145, 156, 178, 191). No detectable ALDP in patient cells (32, 58, 72) due to splicing defect (11, 30).
153008670	c.1866-5C>T  	-	IVS 8	VUS (X:153008670 C/T).
153008673	c.1866-2A>T	p.Pro623fs*? 	IVS 8	Pathogenic, identified in 4 ALD patients (32). No detectable ALDP in patient cells (32) due to splicing defect.
153008677	c.1868C>T	p.Pro623Leu	exon 9	Pathogenic, identified in ALD patient (100).
153008679	c.1870A>G	p.Lys624Glu	exon 9	VUS (X:153008679 A/G) frequency 1/169754 inviduals.
153008685	c.1876G>A	p.Ala626Thr	exon 9	Pathogenic, identified in 13 ALD patients (22, 33, 49, 145, 196). No detectable ALDP in patient cells (22, 33, 49).
153008685	c.[1876G>A; 2087A>T] 	p.[Ala626Thr; Lys696Met]  exon 9 +	exon 10	Pathogenic, identified in ALD patient (32). p.Ala626Thr is pathogenic; p.Lys696Met is a VUS (X:153009038 A/T).
153008685	c.1876G>T	p.Ala626Ser	exon 9	Status unknown (VUS), identified in ALD newborn screening (191).
153008686	c.1877C>A	p.Ala626Asp	exon 9	Pathogenic, identified in ALD patient (49).
153008689	c.1880T>A	p.Leu627His	exon 9	Pathogenic, identified in ALD patient (32).
153008689	c.1880dup	p.Leu628Profs*3	exon 9	Pathogenic, identified in ALD patient (58). Deleterious mutation.
153008690	c.1881C>T	p.Leu627Leu	exon 9	Synonymous (X:153008690 C/T).
153008692	c.1883T>A	p.Leu628Gln	exon 9	Pathogenic, identified in ALD patient (100).
153008692	c.1883T>C	p.Leu628Pro	exon 9	Pathogenic, identified in 3 ALD patients (33, 60). No detectable ALDP in patient cells (60).
153008694	c.1885G>A	p.Asp629Asn	exon 9	Pathogenic, identified in 2 ALD patients (145, 165).
153008694	c.1885G>C	p.Asp629His	exon 9	Pathogenic, identified in ALD patient (22). Normal ALDP level in patient cells (22), but non-functional.
153008697	c.1888G>A	p.Glu630Lys	exon 9	Pathogenic, identified in 2 ALD patients (33, 145).
153008698	c.1889A>G	p.Glu630Gly	exon 9	Pathogenic, identified in ALD patient (49).
153008700	c.1891T>C	p.Cys631Arg	exon 9	Pathogenic, identified in 4 ALD patients (32, 33, 60). No detectable ALDP in patient cells (60).
153008701	c.1892G>A	p.Cys631Tyr	exon 9	Pathogenic, identified in 5 ALD patients (33, 49, 76, 93).
153008702	c.1893C>G	p.Cys631Trp	exon 9	Pathogenic, identified in ALD patient (33).
153008703	c.1894A>C	p.Thr632Pro	exon 9	Pathogenic, identified in 5 ALD patients (33, 96, 100, 120).
153008704	c.1895C>T	p.Thr632Ile	exon 9	Pathogenic, identified in 11 ALD patients (33, 49, 147), confirmed by extensive pedigree analysis (147).
153008707	c.1898G>T	p.Ser633Ile	exon 9	Pathogenic, identified in ALD patient (48).
153008708	c.1899C>T	p.Ser633Ser	exon 9	Synonymous (X:153008708 C/T).
153008708	c.1899delC 	p.Ser633Argfs*3	exon 9	Pathogenic, identified in 4 ALD patients (32, 141). Deleterious mutation. No detectable ALDP in patient cells (141).
153008708	c.1899C>A	p.Ser633Arg	exon 9	Pathogenic, identified in 2 ALD patients (29, 96).
153008709	c.1900G>T	p.Ala634Ser	exon 9	VUS (X:153008709 G/T).
153008709	c.1900G>A	p.Ala634Thr	exon 9	Pathogenic, identified in ALD patient (32).
153008711	c.1902C>T	p.Ala634Ala	exon 9	Synonymous (X:153008711 C/T).
153008712	c.1903G>A	p.Val635Met	exon 9	Pathogenic, identified in 3 ALD patients (32, 49, 58). Affects ALDP stability in patient cells (32, 58).
153008712	c.1903_04insCCA	p.Val635delinsAlaMet 	exon 9	Pathogenic, identified in 2 ALD patients (72, 145). Affects ALDP stability in patient cells (72).
153008715	c.1906delA 	p.Ser636Alafs*55 	exon 9	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008716	c.1907_25del 	p.Ser636Argfs*49 	exon 9	Pathogenic, identified in 3 ALD patients (32). Deleterious mutation.
153008716	c.1907G>T	p.Ser636Ile	exon 9	Pathogenic, identified in 2 ALD patients (27, 42). No detectable ALDP in patient cells (42).
153008718	c.1909A>G	p.Ile637Val	exon 9	VUS (X:153008718 A/G).
153008720	c.1911C>T	p.Ile637Ile	exon 9	Synonymous (X:153008720 C/T).
153008721	c.1912G>T	p.Asp638Tyr	exon 9	Pathogenic, identified in 3 ALD patients (38).
153008723	c.1914C>T	p.Asp638Asp	exon 9	Synonymous (X:153008723 C/T).
153008724	c.1915G>A	p.Val639Met	exon 9	VUS (X:153008724 G/A).
153008727	c.1918G>A	p.Glu640Lys	exon 9	Pathogenic, identified in 4 ALD patients (33, 96).
153008735	c.1926_27insCAAG 	p.Ile643Glnfs*92 	exon 9	Pathogenic, identified in ALD patient (32). Deleterious mutation.
153008742	c.1933C>T	p.Gln645*	exon 9	Pathogenic, identified in 3 ALD patients (22, 33). Deleterious mutation. No detectable ALDP in patient cells (22, 33).
153008742	c.1933del	p.Gln645Argfs*46 	exon 9	Pathogenic, identified in 2 ALD patients (189). Deleterious mutation.
153008745	c.1936G>C	p.Ala646Pro	exon 9	Pathogenic, identified in 2 ALD patients (29, 33).
153008748	c.1939_40insGG 	p.Ala647Glyfs*45 	exon 9	Pathogenic, identified in 4 ALD patients (71, 72). Deleterious mutation. No detectable ALDP in patient cells (72).
153008751	c.1942A>T	p.Lys648*	exon 9	Pathogenic, identified in ALD patient (84). Deleterious mutation.
153008757	c.1948_49del 	p.Ala650Glyfs*83 	exon 9	Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP in patient cells (7).
153008759	c.1950G>A	p.Ala650Ala	exon 9	Synonymous (X:153008759 G/A).
153008770	c.1961T>G	p.Leu654Arg	exon 9	Pathogenic, identified in ALD patient (33).
153008770	c.1961T>C	p.Leu654Pro	exon 9	Pathogenic, identified in 19 ALD patients (32, 49, 62, 97, 139, 141). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 49, 139, 141).
153008773	c.1964T>C	p.Leu655Pro	exon 9	Pathogenic, identified in ALD patient (53). Affects ALDP stability in patient cells (53).
153008776	c.1967C>T	p.Ser656Phe	exon 9	Pathogenic, identified in ALD patient (33).
153008779	c.1970_72del 	p.Ile657del	exon 9	Pathogenic, identified in 12 ALD patients (16, 32, 33, 111, 141, 185). No detectable ALDP in patient cells (32, 141).
153008782	c.1973C>T	p.Thr658Ile	exon 9	Pathogenic, identified in 2 ALD patients (33, 58). No detectable ALDP in patient cells (58).
153008787	c.1978C>T	p.Arg660Trp	exon 9	Pathogenic, identified in 43 ALD patients (7, 13, 16, 22, 23, 24, 32, 33, 49, 53, 57, 58, 60, 88, 90, 97, 135, 141, 145, 146, 190, 191). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (7, 22, 23, 32, 33, 49, 53, 58, 141, 146).
153008788	c.1979G>A	p.Arg660Gln	exon 9	Pathogenic, identified in 5 ALD patients (71, 72, 150). No detectable ALDP in patient cells (72).
153008788	c.1979G>T	p.Arg660Leu	exon 9	Status unknown (VUS), identified in ALD newborn screening (191).
153008788	c.1979G>C	p.Arg660Pro	exon 9	Pathogenic, identified in ALD patient (48).
153008791	c.1982_83del 	p.Pro661Leufs*72 	exon 9	Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
153008797	c.1988T>A	p.Leu663Gln	exon 9	Pathogenic, identified in 2 ALD patients (32, 58). Affects ALDP stability in patient cells (32, 58).
153008797	c.1988_89insT	p.Trp664Valfs*70 	exon 9	Pathogenic, identified in 2 ALD patients (33, 49). Deleterious mutation. No detectable ALDP in patient cells (33).
153008801	c.1991+1G>A	p.Lys665fs*? 	IVS 9	Pathogenic, identified in ALD patient (49). Deleterious mutation.
153008802	c.1991+2T>C	p.Lys665fs*? 	IVS 9	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008805	c.1991+5G>T  	-	IVS 9	VUS (X:153008805 G/T).
153008807	c.1991+7G>A  	-	IVS 9	VUS (X:153008807 G/A) frequency 5/130456 inviduals.
153008941	c.1992-2A>G	p.Lys665fs*? 	IVS 9	Pathogenic, identified in 5 ALD patients (32, 199). Deleterious mutation.
153008942	c.1992-1G>A	p.Lys665fs*? 	IVS 9	Pathogenic, identified in ALD patient (49). Deleterious mutation.
153008943	c.1992G>A	p.Trp664*	exon 10	Pathogenic, identified in ALD patient (98). Deleterious mutation.
153008944	c.1993_95delinsGAG 	p.Lys665delinsGlu	exon 10	Pathogenic, identified in ALD patient (72). Affects ALDP stability in patient cells (72).
153008945	c.1994A>C	p.Lys665Thr	exon 10	VUS (X:153008945 A/C) frequency 1/165162 inviduals.
153008948	c.[1997A>C;2007C>G]	p.[Tyr666Ser;His669Gln]	exon 10	Pathogenic, identified in ALD patient (62). Unclear which of the two variants is pathogenic.
153008949	c.1998C>G	p.Tyr666*	exon 10	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008950	c.1999C>G	p.His667Asp	exon 10	Pathogenic, identified in 4 ALD patients (49, 62, 90, 97). Reduced (3% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (49).
153008950	c.1999_2000delCA 	p.His669Leufs*64 	exon 10	Pathogenic, identified in ALD patient (29). Deleterious mutation.
153008951	c.2000A>G	p.His667Arg	exon 10	Pathogenic, identified in ALD patient (33).
153008951	c.2000A>T	p.His667Leu	exon 10	Pathogenic, identified in ALD patient (53). Affects ALDP stability in patient cells (53).
153008953	c.2002A>C	p.Thr668Pro	exon 10	Pathogenic, identified in ALD patient (33).
153008954	c.2003C>T	p.Thr668Ile	exon 10	Pathogenic, identified in 2 ALD patients (33, 49). No detectable ALDP in patient cells (49).
153008957	c.2006_07del 	p.His669Leufs*64 	exon 10	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008957	c.2006_2007dup 	p.Leu670Thrfs*22 	exon 10	Pathogenic, identified in ALD newborn screening (191). Deleterious mutation.
153008957	c.2006A>G	p.His669Arg	exon 10	Pathogenic, identified in 7 ALD patients (33, 58, 104, 135, 145). No detectable ALDP in patient cells (58).
153008958	c.[2007C>G;1997A>C]	p.[His669Gln;Tyr666Ser]	exon 10	Pathogenic, identified in ALD patient (62). Unclear which of the two variants is pathogenic.
153008961	c.2010_11insT	p.Leu671Serfs*63 	exon 10	Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008961	c.2010_2014delinsTAT 	p.Leu670Phefs*63 	exon 10	Pathogenic, identified in 3 ALD patients (87). Deleterious mutation.
153008961	c.2010dupG 	p.Leu671Alafs*63 	exon 10	Pathogenic, identified in ALD patient (181). Deleterious mutation.
153008965	c.2014C>T	p.Gln672*	exon 10	Pathogenic, identified in 6 ALD patients (25, 27, 28, 33, 87, 88). Deleterious mutation. No detectable ALDP in patient cells (25).
153008970	c.2019C>T	p.Phe673Phe	exon 10	Synonymous (X:153008970 C/T).
153008970	c.2019C>G	p.Phe673Leu	exon 10	VUS (X:153008970 C/G) frequency 2/164208 inviduals.
153008971	c.2020G>A	p.Asp674Asn	exon 10	VUS (X:153008971 G/A) frequency 1/21495 inviduals.
153008974	c.2023G>T	p.Gly675Trp	exon 10	Status unknown (VUS), identified in ALD newborn screening (191).
153008977	c.2026G>T	p.Glu676*	exon 10	Pathogenic, identified in 2 ALD patients (33). Deleterious mutation.
153008981	c.2030G>A	p.Gly677Asp	exon 10	Pathogenic, identified in ALD patient (96).
153008982	c.2031C>T	p.Gly677Gly	exon 10	Synonymous (X:153008982 C/T).
153008983	c.2032G>A	p.Gly678Ser	exon 10	VUS (X:153008983 G/A) frequency 1/21526 inviduals.
153008984	c.2033G>A	p.Gly678Asp	exon 10	VUS (X:153008984 G/A).
153008986	c.2035T>C	p.Trp679Arg	exon 10	Pathogenic, identified in 3 ALD patients (14, 88).
153008987	c.2036G>A	p.Trp679*	exon 10	Pathogenic, identified in ALD patient (84). Deleterious mutation.
153008988	c.2037G>A	p.Trp679*	exon 10	Pathogenic, identified in 6 ALD patients (32, 33, 100, 154). Deleterious mutation.
153008994	c.2043C>T	p.Phe681Phe	exon 10	Synonymous (X:153008994 C/T).
153008994	c.2043C>G	p.Phe681Leu	exon 10	Benign, based on its frequency of 26/181918 inviduals (X:153008994 C/G).
153008995	c.2044G>C	p.Glu682Gln	exon 10	Benign, based on its frequency of 13/181548 inviduals (X:153008995 G/C).
153009002	c.2051T>C	p.Leu684Pro	exon 10	Pathogenic, identified in ALD patient (33).
153009012	c.2061_2200del 	p.Leu690Profs*65 	exon 10	Pathogenic, identified in ALD patient (32). Deleterious mutation.
153009016	c.2065C>T	p.Arg689Cys	exon 10	Benign, based on its frequency of 12/176163 inviduals (X:153009016 C/T).
153009024	c.2073C>G	p.Ser691Arg	exon 10	VUS (X:153009024 C/G).
153009029	c.2078C>T	p.Thr693Met	exon 10	Pathogenic, identified in ALD patient (49). Normal ALDP level in patient cells (49), but non-functional.
153009038	c.2087A>T	p.Lys696Met	exon 10	VUS (X:153009038 A/T) frequency 8/151181 inviduals.
153009041	c.2090A>G	p.Gln697Arg	exon 10	VUS (X:153009041 A/G) frequency 3/147671 inviduals.
153009062	c.2111C>T	p.Ala704Val	exon 10	VUS (X:153009062 C/T).
153009063	c.2112G>A	p.Ala704Ala	exon 10	Synonymous (X:153009063 G/A).
153009074	c.2123A>G	p.Lys708Arg	exon 10	VUS (X:153009074 A/G) frequency 1/21422 inviduals.
153009078	c.2127G>A	p.Met709Ile	exon 10	VUS (X:153009078 G/A) frequency 2/136452 inviduals.
153009082	c.2131C>T	p.Arg711Trp	exon 10	VUS (X:153009082 C/T).
153009083	c.2132G>A	p.Arg711Gln	exon 10	VUS (X:153009083 G/A) frequency 3/132083 inviduals.
153009086	c.2135G>C	p.Arg712Pro	exon 10	Status unknown (VUS), identified in ALD newborn screening (191).
153009089	c.2138T>C	p.Leu713Pro	exon 10	VUS (X:153009089 T/C) frequency 1/130825 inviduals.
153009094	c.2143G>A	p.Glu715Lys	exon 10	VUS (X:153009094 G/A) frequency 1/21236 inviduals.
153009109	c.2158C>G	p.Leu720Val	exon 10	VUS (X:153009109 C/G).
153009124	c.2173G>A	p.Ala725Thr	exon 10	VUS (X:153009124 G/A) frequency 4/114962 inviduals.
153009136	c.2185G>A	p.Val729Met	exon 10	VUS (X:153009136 G/A) frequency 1/111788 inviduals.
153009140	c.2189C>T	p.Pro730Leu	exon 10	VUS (X:153009140 C/T) frequency 4/130292 inviduals.
153009141	c.2190G>A	p.Pro730Pro	exon 10	Synonymous (X:153009141 G/A).
153009152	c.2201C>G	p.Pro734Arg	exon 10	VUS (X:153009152 C/G) frequency 3/127737 inviduals.
153009152	c.2201C>T	p.Pro734Leu	exon 10	VUS (X:153009152 C/T) frequency 9/127737 inviduals.
153009153	c.2202G>A	p.Pro734Pro	exon 10	Synonymous (X:153009153 G/A).
153009160	c.2209C>T	p.Pro737Ser	exon 10	VUS (X:153009160 C/T) frequency 1/20978 inviduals.
153009173	c.2222A>G	p.Gln741Arg	exon 10	VUS (X:153009173 A/G).
153009176	c.2225G>T	p.Gly742Val	exon 10	VUS (X:153009176 G/T).
153009184	c.2233A>C	p.Thr745Pro	exon 10	VUS (X:153009184 A/C).
153009190	c.2238*1C>T  	-	3′ UTR	VUS (X:153009190 C/T).
153009196	c.2238*7C>T  	-	3′ UTR	VUS (X:153009196 C/T).
153009197	c.2238*8G>C  	-	3′ UTR	Benign, based on its frequency of 81685/120445 inviduals (X:153009197 G/C).
